This article provides an in-depth exploration of Computer-Assisted Structure Elucidation (CASE) systems and their transformative role in natural product research and drug development.
This article provides an in-depth exploration of Computer-Assisted Structure Elucidation (CASE) systems and their transformative role in natural product research and drug development. Tailored for researchers, scientists, and drug development professionals, it covers the foundational evolution of CASE from 1D to 2D NMR-based systems[citation:1], details modern methodological workflows that integrate spectral data for de novo structure generation[citation:2][citation:4], addresses common troubleshooting scenarios and optimization strategies for complex molecules[citation:1][citation:3], and evaluates validation protocols and comparative performance of leading CASE platforms[citation:3][citation:9]. The synthesis of these four core intents highlights how CASE enhances accuracy, accelerates discovery, and reduces structural misassignments in biomedical research.
The structure elucidation of complex natural products represents a fundamental challenge in drug discovery and chemical research. For decades, Nuclear Magnetic Resonance (NMR) spectroscopy has served as the primary analytical tool for this task [1]. The historical trajectory from one-dimensional (1D) to two-dimensional (2D) NMR experiments marked a revolutionary advance, providing the detailed through-bond and through-space correlations necessary to unravel complex molecular architectures [2]. In parallel, the field of Computer-Assisted Structure Elucidation (CASE) evolved from theoretical concepts in the late 1960s to sophisticated expert systems that now integrate these multidimensional NMR datasets [3] [4]. Within the context of a broader thesis on CASE for natural products, this article details the critical pathway of this technological synergy. It outlines the key application notes, provides definitive experimental protocols for cornerstone 2D NMR experiments, and demonstrates how modern expert systems leverage this data to solve structures with unprecedented speed and accuracy, minimizing the risk of erroneous assignments that persist in the literature [1] [5].
The development of NMR and CASE is a story of incremental foundational discoveries followed by transformative technological leaps. The initial observation of nuclear magnetic resonance in bulk materials was independently reported by Felix Bloch and Edward Purcell in 1946 [6]. The subsequent award of the Nobel Prize in Physics in 1952 confirmed the technique's significance. Early applications in chemistry relied on 1D spectra of nuclei like ¹H and ¹³C [7] [6]. While providing critical information on chemical environment, 1D NMR lacked the power to directly trace atomic connectivity in complex molecules, creating a bottleneck for structure elucidation [4].
The conceptual breakthrough for 2D NMR came from Jean Jeener in 1971, with the first practical implementation of Correlation Spectroscopy (COSY) by Aue, Bartholdi, and Ernst in 1976 [2]. This introduced a second frequency dimension, spreading out spectral data and allowing the correlation of coupled nuclei. The subsequent development of experiments like TOCSY, HSQC, and HMBC provided a comprehensive toolkit for establishing molecular connectivities [2]. The routine availability of these 2D experiments in the 1990s provided the rich, interconnected datasets required to make CASE a practical reality [3] [8].
Simultaneously, the field of CASE was born in 1968 with early systems attempting to use infrared and 1D NMR data [3] [4]. These initial systems were limited to small, simple molecules. The pivotal moment arrived when CASE algorithms were redesigned to ingest and process the correlation data from 2D NMR experiments [9] [4]. This integration enabled expert systems to solve increasingly complex problems, culminating in modern software capable of outperforming human experts in speed and often in reliability for planar structure determination [9] [3].
Table 1: Key Historical Milestones in NMR and CASE Development
| Year | Milestone | Key Contributors/Systems | Significance |
|---|---|---|---|
| 1946 | First detection of NMR in bulk materials | Bloch; Purcell, Torrey, Pound [6] | Foundation of NMR spectroscopy. |
| 1952 | Nobel Prize in Physics for NMR discovery | Felix Bloch, Edward Purcell [6] | Recognition of NMR's fundamental importance. |
| 1968 | First publications on CASE methods | Elyashberg, Gribov et al. [3] | Birth of computer-assisted structure elucidation. |
| 1971 / 1976 | Concept and first implementation of 2D NMR (COSY) | Jeener; Aue, Bartholdi, Ernst [2] | Introduction of a second spectral dimension, enabling correlation spectroscopy. |
| 1990s | 2D NMR becomes routine; CASE systems begin using 2D data | - [3] [4] [8] | Provides the necessary data density for effective CASE application to complex molecules. |
| 1997 | Development of ACD/Structure Elucidator begins | Mikhail Elyashberg & ACD/Labs [9] [3] | Creation of a leading commercial CASE expert system. |
| 2003 | First report of a CASE system outperforming human experts | ACD/Structure Elucidator [3] | Demonstrated the practical power of automated elucidation. |
| 2020s | CASE systems solve complex natural products with 100% success in challenges | Modern CASE programs (e.g., ACD/SE) [9] [3] | Maturation of expert systems as reliable, high-throughput tools for research. |
Modern structure elucidation of natural products relies on a suite of complementary 2D NMR experiments. Each provides specific pieces of the structural puzzle, from direct bond connections to long-range relationships and spatial proximity.
Application Note: The COSY experiment identifies nuclei that are coupled through a small number of bonds (typically 2-3 bonds for vicinal protons) [2]. It is the primary tool for establishing the proton-proton connectivity network within a spin system, such as along a carbon chain or around a ring system.
Detailed Protocol:
Application Note: The HSQC experiment correlates directly bonded protons and heteronuclei (e.g., ¹H to ¹³C). It provides a critical "map" assigning each proton to its directly attached carbon atom, differentiating CH, CH₂, and CH₃ groups.
Detailed Protocol:
Application Note: HMBC is arguably the most powerful experiment for skeletal assembly. It detects correlations between protons and carbons (or other heteronuclei) separated by 2-3 bonds (²,³JCH), and sometimes 4 bonds [9] [4]. This "long-range" connectivity links molecular fragments together through quaternary centers.
Detailed Protocol:
Table 2: Key 2D NMR Experiments for Natural Product Structure Elucidation
| Experiment | Correlation Type | Typical Range (Bonds) | Primary Application in Structure Elucidation | Key Limitation/Caution |
|---|---|---|---|---|
| COSY | ¹H ¹H (homonuclear) | 2-3 (vicinal) [2] | Establishes proton connectivity within spin systems. | Cannot link protons across quaternary centers or large coupling distances. |
| TOCSY | ¹H ¹H (homonuclear) | Entire spin system [2] | Identifies all protons within an isolated coupled network (e.g., a single sugar residue). | Mixing time determines extent of correlation; can be complex in overlapping systems. |
| HSQC | ¹H ¹³C (heteronuclear, 1-bond) | 1 (direct bond) | Assigns protons to their directly attached carbons; identifies CHₙ multiplicity. | Does not provide connectivity information between fragments. |
| HMBC | ¹H ¹³C (heteronuclear, long-range) | 2-3 (²,³JCH), sometimes 4 [9] | Most critical for skeleton assembly. Connects structural fragments via quaternary carbons and heteroatoms. | Presence of non-standard correlations (>3 bonds) can cause ambiguity if not handled properly [4]. |
Diagram Title: Integrated CASE Workflow from 2D NMR Data to Structure
The integration of 2D NMR data into CASE systems transformed them from simple fragment assemblers into powerful expert systems. A leading example, ACD/Structure Elucidator (ACD/SE), exemplifies this architecture [9].
System Architecture and Workflow:
Diagram Title: Evolution from 1D NMR to 2D NMR Expert Systems
Table 3: Essential Research Reagent Solutions for 2D NMR-Based Structure Elucidation
| Item | Specification / Example | Function in Protocol |
|---|---|---|
| Deuterated NMR Solvents | CDCl₃, DMSO-d₆, CD₃OD, D₂O | Provides a signal for the spectrometer lock system and dissolves the sample without adding interfering proton signals. |
| NMR Reference Standard | Tetramethylsilane (TMS) or solvent residual peak (e.g., CHCl₃ at 7.26 ppm in CDCl₃) | Provides a reference point (0 ppm) for calibrating the chemical shift scale of the spectrum. |
| High-Purity Natural Product Sample | 2-10 mg, purified via HPLC/LCMS | The analyte of interest. Purity is critical to avoid overlapping signals from impurities. |
| Shigemi or Standard NMR Tube | 5 mm outer diameter, matched for the spectrometer | Holds the sample in the magnetic field. Shigemi tubes allow for smaller sample volumes. |
| CASE Expert System Software | ACD/Structure Elucidator, or similar [9] [3] | The software platform that automates data interpretation, structure generation, and ranking. |
| NMR Prediction Software | Integrated in CASE or standalone (e.g., ACD/NMR Predictors, DFT software) | Calculates expected NMR spectra for candidate structures to enable ranking and verification [9] [8]. |
The historical development from 1D NMR beginnings to modern 2D NMR expert systems has fundamentally reshaped natural products research. CASE systems, built upon the rich correlation data from experiments like HMBC and COSY, have matured into indispensable tools that provide unbiased, thorough, and rapid structural hypotheses [3] [8]. They systematically address the challenge of non-standard correlations and can now reliably elucidate structures that have stymied experts for years [9] [4].
Future advancements point toward even greater integration and automation. The incorporation of more sophisticated quantum mechanical calculations, such as Density Functional Theory (DFT), for both chemical shift prediction and 3D conformation analysis is ongoing [1] [8]. Research into quantum sensing using defects in 2D materials like hexagonal boron nitride promises the potential for NMR detection at the single-molecule level, which could revolutionize sensitivity [10]. Furthermore, the integration of CASE systems directly with spectroscopic hardware for automated, on-the-fly analysis represents the next frontier in high-throughput structure elucidation [4]. As these tools become more accessible and user-friendly, their application is expected to become standard practice, ensuring greater accuracy and efficiency in discovering and characterizing the complex molecules that serve as the foundation for new therapeutics [8].
The discovery of novel bioactive natural products (NPs) is systematically hindered by two major bottlenecks: the re-isolation of known compounds and the arduous process of solving novel chemical structures [11]. Within the framework of a broader thesis on Computer-Assisted Structure Elucidation (CASE), this article defines and delineates three critical, interdependent processes: dereplication, structure verification, and de novo structure elucidation. These processes represent points on a continuum of analytical certainty, from identification to full structural discovery [12].
Dereplication acts as the essential first filter, aiming to rapidly identify known compounds in a mixture to prioritize novel leads [11] [13]. Structure verification serves as a confirmatory checkpoint, typically using spectroscopic data to validate that an isolated compound matches a hypothesized or expected structure [14] [12]. De novo elucidation is the most complex undertaking, involving the complete and unbiased determination of an unknown chemical structure from analytical data alone [15] [12]. Modern CASE systems synergize data from multiple spectroscopic techniques—primarily Nuclear Magnetic Resonance (NMR) and high-resolution tandem Mass Spectrometry (HR-MS/MS)—with computational algorithms and database mining to accelerate and objectify each of these processes [14] [15] [11]. This integration is transforming NP research from a serendipitous, one-off process into a high-throughput, predictive discovery pipeline [16] [17].
The successful application of CASE requires a clear understanding of the distinct inputs, objectives, and outputs for dereplication, verification, and elucidation. The following table summarizes their defining characteristics and roles within the NP discovery workflow.
Table 1: Core Characteristics of Dereplication, Verification, and De Novo Elucidation
| Aspect | Dereplication | Structure Verification | De Novo Structure Elucidation |
|---|---|---|---|
| Primary Goal | Early, rapid identification of known compounds to avoid redundancy. | Confirm or refute a proposed chemical structure. | Determine the complete, unknown chemical structure from analytical data. |
| Typical Input | Crude or partially purified extract; HR-MS/MS data; sometimes 1D NMR. | Purified compound; a proposed candidate structure; full suite of 1D/2D NMR and MS data. | Purified compound of unknown structure; comprehensive 1D/2D NMR and HR-MS/MS data. |
| Key Analytical Tools | LC-HRMS, MS/MS, molecular networking, database search (e.g., GNPS). | NMR prediction & comparison, MS fragmentation matching, automated verification (ASV) software. | CASE expert systems (e.g., ACD/Structure Elucidator), DFT-NMR calculations, SIRIUS. |
| Data Interpretation | Comparative: Searches against spectral or structural libraries. | Confirmatory: Assesses consistency between data and a single candidate. | Generative: Uses data as constraints to mathematically enumerate all possible structures. |
| Output | Identity of known compound or close analogue; "novelty flag." | Binary result (Confirmed/Rejected) with confidence scoring; may suggest alternatives. | One or more candidate structures ranked by probability; often a single definitive solution. |
| Role in NP Workflow | Priority filter at the extract stage. | Quality control check after isolation or synthesis. | Discovery engine for novel chemical entities. |
The operationalization of these concepts relies on specific computational workflows. Their effectiveness is benchmarked using quantitative metrics, as summarized below.
Table 2: Performance Metrics of Key CASE and Dereplication Tools
| Tool/Method | Type | Key Metric | Reported Performance | Application Context |
|---|---|---|---|---|
| SIRIUS 4 [18] | De Novo MS Annotation | Correct Identification Rate | >70% when searching fragmentation spectra in a structure database. | Molecular formula annotation and structure prediction from HR-MS/MS data. |
| DEREPLICATOR [16] | Peptidic NP Dereplication | False Discovery Rate (FDR) | 7.3% FDR at peptide level (p-value threshold 10⁻¹⁰) in GNPS spectra search. | High-throughput identification of known PNPs and their variants from MS/MS data. |
| MSⁿ Spectral Trees [19] | Spectral Library Matching | Library Size & Validation | 872 MSⁿ spectra from 549 metabolites; validated with 765 replicate spectra. | Metabolite identification via automated comparison of multistage mass spectral trees. |
| CASE + DFT [15] | De Novo Elucidation/Verification | Problem-Solving Capability | Successfully resolved challenging NPs (aquatolide, coniothyrione) where empirical prediction failed. | Definitive structure verification and revision of complex stereochemistry. |
| Structure-Based Screening [20] | Virtual Dereplication | Library Screening Scale | Screened 26,311 NP structures against SARS-CoV-2 targets using 60% similarity cut-off. | Identifying NPs with structural and pharmacological similarity to known drugs. |
Workflow Overview: The hierarchical relationship between these processes can be visualized as a decision tree that guides researchers from initial analysis to final confirmation.
Objective: To rapidly identify known metabolites in crude fermentation broths or microbial colony extracts [13]. Materials: LC-HRMS system (e.g., Q-TOF or Orbitrap); Global Natural Products Social Molecular Networking (GNPS) platform; SIRIUS 4 software [11] [18].
Objective: To objectively confirm the identity of a purified compound against a proposed structure without analytical bias [14] [12]. Materials: Pure compound (>1 mg); NMR spectrometer (≥400 MHz); ASV software (e.g., ACD/Labs ASV, MestReNova).
Objective: To determine the complete planar and stereochemical structure of an unknown natural product [15]. Materials: Purified unknown compound (2-5 mg); NMR spectrometer (≥500 MHz recommended); CASE software (e.g., ACD/Structure Elucidator); DFT computation software (e.g., Gaussian).
Integrated CASE Workflow: The synergy of spectroscopic data, CASE logic, and quantum mechanical calculations forms a powerful pipeline for definitive elucidation.
Table 3: Key Software and Database Tools for CASE Workflows
| Tool Name | Category | Primary Function | Application Scope |
|---|---|---|---|
| ACD/Structure Elucidator [14] [15] | CASE Expert System | De novo structure generation from NMR/MS constraints. | Core engine for solving unknown structures. |
| GNPS & DEREPLICATOR [16] [11] | Cloud Platform & Algorithm | Mass spectral networking, library search, and PNP dereplication. | High-throughput dereplication and analog discovery. |
| SIRIUS 4 [18] | MS Data Analysis | Molecular formula identification and fragmentation tree analysis. | De novo annotation when no library match exists. |
| Mestrelab Mnova | NMR/MS Processing | NMR data analysis, verification (ASV), and reporting. | Unified platform for processing and verifying spectroscopic data. |
| AntiMarin Database [16] | Chemical Database | Curated database of marine natural products and PNPs. | Target database for specialized dereplication searches. |
| Gaussian | Quantum Chemistry | DFT calculations for NMR chemical shift and energy prediction. | Definitive stereochemical assignment and CASE validation. |
| Osiris DataWarrior [20] | Chemoinformatics | Property calculation, structural similarity screening, and filtering. | Pre-filtering NP libraries based on properties and similarity. |
The structural elucidation of complex natural products (NPs) represents a formidable challenge in drug discovery and chemical research. These molecules possess unparalleled architectural diversity and stereochemical complexity, which are key drivers of their potent and selective bioactivities. However, these same features render their definitive structural characterization using traditional methods prone to error and inefficiency [1] [21]. This document frames these challenges within the transformative context of Computer-Assisted Structure Elucidation (CASE), a paradigm that is fundamentally reshaping NP research. Modern CASE systems act as expert partners, integrating spectroscopic data—primarily 2D NMR correlations—with computational chemistry and database knowledge to generate and rank all plausible structural hypotheses [1] [22]. This shift from manual interpretation to data-driven, algorithmic analysis is mitigating the high rate of incorrect structure assignments historically reported in the literature and is accelerating the transition from crude extract to validated molecular structure [1] [23]. The protocols herein detail the application of an integrated CASE workflow, designed to harness key technological drivers—advanced NMR experiments, high-resolution mass spectrometry (HRMS), and predictive computational models—to systematically decode NP complexity.
CASE systems operate on the core principle of systematic structure generation constrained by empirical spectroscopic data. The primary inputs are atom connectivity rules derived from 2D NMR experiments, particularly ^1H-^1H COSY (homonuclear correlation) and ^1H-^13C HMBC (heteronuclear multiple-bond correlation). A foundational, though sometimes limiting, assumption is that all observed HMBC correlations correspond to ^2J_CH or ^3J_CH couplings (2- or 3-bond relationships) [1]. The system uses these constraints to assemble molecular connectivity lists, from which it generates all possible planar chemical structures that do not violate the input data. These candidate structures are then ranked using probabilistic methods or by comparing predicted NMR chemical shifts (calculated via empirical or Density Functional Theory (DFT) methods) with the experimental dataset [22]. The output is not a single answer but a ranked list of plausible structures, providing a quantifiable measure of confidence and highlighting potential ambiguities for further experimental investigation. This process directly addresses NP complexity by exhaustively exploring chemical space defined by the data, reducing human bias and oversight [1].
Table 1: Comparison of Representative CASE Systems and Their Methodological Focus
| System / Approach | Primary Data Inputs | Core Algorithmic Method | Key Strength | Reported Limitation / Challenge |
|---|---|---|---|---|
| Structure Elucidator (ACD/Labs) | 1D/2D NMR (COSY, HSQC, HMBC), MS, Molecular Formula [22] | Deterministic Structure Generator + NMR Prediction & Ranking | Robust handling of complex, proton-deficient molecules; extensive database integration. | Performance can degrade with violations of the 2-/3-bond HMBC assumption or very high molecular symmetry [1]. |
| Cologne University System | 2D NMR Correlations (COSY, HMBC) [1] | Fragmentation & Reassembly Logic | Effective at identifying structural fragments from correlation data prior to full assembly. | Requires careful user validation of generated fragments; less automated than full black-box systems. |
| Stochastic CASE Programs | NMR correlations, optional MS & IR data [23] | Stochastic (Monte Carlo) Search Algorithms | Can escape local minima in structure space; useful for novel scaffolds with few database analogues. | Computationally intensive; may require more user intervention to guide the search. |
| DFT-NMR Integrated Workflow | 2D NMR Data + High-Level DFT Calculations (e.g., GIAO) [1] [22] | CASE Generation followed by DFT-NMR Shift Prediction & DP4 Analysis | Provides extremely high confidence in stereochemistry and structural validation; gold standard for complex cases. | Computationally expensive (days of CPU time); requires expertise in computational chemistry setup. |
| AI/ML-Enhanced Prediction | Broad spectral datasets, structural databases [24] | Machine Learning (e.g., Neural Networks) for shift prediction or substructure recognition | Potential for rapid, direct prediction from raw or pre-processed spectral data. | Currently emerging; dependent on quality, size, and diversity of training datasets [25] [24]. |
Objective: To prepare a comprehensive and high-quality spectroscopic dataset suitable for reliable CASE analysis.
Materials:
_3OD, DMSO-d_6).^1H frequency recommended).Procedure:
_3CN).^+, [M+Na]^+, [M-H]^-)._30H_48O_4). This formula is a mandatory constraint for the CASE system, dramatically reducing the combinatorial space for structure generation [25].NMR Sample Preparation & 1D Acquisition:
^1H NMR and ^13C NMR (or edited HSQC for ^13C chemical shifts) spectra.^1H spectrum has a high signal-to-noise ratio (SNR > 50:1 for key resonances) and is properly phased and baseline-corrected.Essential 2D NMR Experiments for CASE:
^1H-^1H COSY: Identifies ^3J_HH coupling networks (geminal and vicinal protons). Use sufficient resolution to resolve overlapping cross-peaks.^1H-^13C one-bond correlations. This defines the CH, CH_2, and CH_3 groups in the molecule.^nJ_CH of ~8 Hz (typical for ^2J and ^3J). Acquire with a long acquisition time in the indirect dimension to maximize resolution. Explicitly note any very weak or potentially long-range (^4J_CH or greater) correlations during data analysis, as these violate standard CASE assumptions and must be treated carefully [1].Data Export: Export all processed spectra (peak lists and, ideally, FID data) in a format compatible with the target CASE software (e.g., JCAMP-DX, Bruker, Varian formats).
Objective: To convert spectroscopic data into a ranked list of candidate structures.
Materials:
^1H & ^13C chemical shifts, COSY, HSQC, and HMBC correlations.Procedure:
Setting Parameters and Generating Structures:
Structure Ranking and Analysis:
Objective: To unambiguously confirm the top CASE-derived planar structure and determine its relative/absolute stereochemistry.
Materials:
Procedure:
DFT Geometry Optimization and NMR Calculation:
^1H and ^13C NMR chemical shifts using the GIAO (Gauge-Independent Atomic Orbital) method with a higher basis set (e.g., B3LYP/6-311+G(2d,p)) and a solvent model (PCM or SMD) [1] [22].Averaging and Statistical Analysis (DP4 Protocol):
Objective: To rapidly identify known compounds in a mixture prior to full isolation and CASE analysis, saving resources.
Materials:
Procedure:
Diagram 1: Integrated CASE Workflow for NP Structure Elucidation (Max Width: 760px)
Table 2: Key Research Reagent Solutions for CASE-Driven NP Elucidation
| Item / Solution | Function / Purpose | Critical Application Notes |
|---|---|---|
Deuterated NMR Solvents (e.g., CD_3OD, DMSO-d_6, CDCl_3) |
Provides the locking signal for NMR spectrometers and minimizes interfering ^1H signals from the solvent. |
Select solvent that optimally dissolves the NP. Use highest isotopic purity (e.g., 99.96% D) to minimize residual solvent ^1H peaks. |
| NMR Tube with Coaxial Insert | Allows for the inclusion of a secondary standard (e.g., TMS in CDCl_3) without contaminating the primary sample. |
Essential for precise, reproducible chemical shift referencing, a critical input for CASE and DFT calculations. |
LC-MS Grade Solvents (MeOH, CH_3CN, H_2O with 0.1% Formic Acid) |
Used for sample preparation for HRMS and LC-MS de-replication. | High purity minimizes background ions, ensuring accurate mass determination and clean MS/MS spectra for database matching [25]. |
| Reference Standard for HRMS Calibration (e.g., Sodium Formate, Agilent Tuning Mix) | Enables external or internal mass calibration of the HRMS instrument. | Mandatory for achieving <3 ppm mass accuracy required for definitive molecular formula assignment. |
| Software Suite: CASE Program (e.g., ACD/SE), NMR Processing, DFT Package | The digital toolkit for data processing, structure generation, and quantum mechanical validation. | Ensure compatibility of spectral data formats between the NMR spectrometer software and the CASE program. |
| Structural Databases (Commercial: DNP, AntiBase; Public: GNPS, PubChem) | Used for de-replication and to provide prior knowledge for CASE systems' internal libraries. | Regular updates are necessary to include newly reported NPs and avoid redundant "rediscovery" [21] [24]. |
This application note details the operational framework of Computer-Assisted Structure Elucidation (CASE) within natural products research. CASE systems are expert systems designed to drastically reduce the time and effort required to determine the structures of newly isolated organic compounds by integrating spectroscopic data with logical-combinatorial algorithms [26]. The elucidation process hinges on three fundamental components: the molecular formula, which defines the search space; spectral data (NMR, MS, IR, UV), which provide structural constraints; and structure generators, the algorithmic engines that assemble candidate molecules [26] [27]. Modern advancements are revolutionizing this field, including the integration of vast, open-access spectral and structural databases [28] [29], the development of open-source CASE platforms [30], and the emergence of generative artificial intelligence models capable of end-to-end structure prediction from spectral data [31]. This document provides detailed protocols for contemporary CASE workflows, visualizes the logical architecture, and catalogues the essential toolkit for researchers engaged in the discovery and characterization of natural products.
The structural elucidation of unknown organic compounds, a cornerstone of natural products chemistry and drug discovery, is a complex, multi-stage puzzle. For over half a century, Computer-Assisted Structure Elucidation (CASE) systems have been developed to emulate and enhance the reasoning of an expert spectroscopist [26] [27]. These systems are particularly vital for natural products research, where molecules are often structurally novel, complex, and isolated in minute quantities. The core challenge CASE addresses is combinatorial explosion: a single molecular formula can correspond to billions of possible structural isomers, a number that grows astronomically for medium-sized molecules [26]. CASE strategies navigate this vast chemical space by systematically applying structural constraints derived from experimental spectra to eliminate incorrect candidates. The resurgence of interest in CASE is driven by the increasing availability of high-resolution 2D NMR and mass spectrometry data, powerful open-source software tools [30], and comprehensive public databases like the Natural Products Atlas [29] and GNPS [28]. Furthermore, the field is on the cusp of a paradigm shift with the introduction of deep learning models that promise to bypass traditional combinatorial generation for a direct, predictive approach [31].
The molecular formula (MF), typically determined via high-resolution mass spectrometry (HR-MS), is the essential starting point for any de novo CASE analysis. It defines the atomic composition of the unknown compound, setting the absolute boundaries of the chemical space to be explored. The MF is a critical filter because the number of possible structural isomers it represents is finite but immense. An expert system uses the MF, along with standard valency rules, as the primary input for its structure generator [27] [32]. Accurate determination is paramount, as an incorrect formula will preclude finding the correct structure.
Table 1: Impact of Molecular Formula Complexity on Isomer Count
| Molecular Formula | Compound Class Example | Approximate Number of Possible Structural Isomers | CASE Strategy Implication |
|---|---|---|---|
| C₆H₆O | Simple phenol derivative | ~1 Million [26] | Exhaustive structure generation is feasible. |
| C₁₀H₂₀O | Monoterpenoid | ~10¹⁰ (Billions) [26] | Fragment-based generation is necessary to constrain search. |
| C₂₀H₃₀O₂ | Diterpenoid | ~10²⁰ – 10³⁰ [26] | Heavy reliance on 2D NMR-derived fragments and constraints is essential. |
| C₃₀H₄₈O₃ | Triterpenoid | >10³⁰ (Avogadro-scale) [26] | Requires maximal spectral constraints and often stochastic or AI-driven generation. |
Application Note: For natural products, the MF often provides initial biosynthetic clues (e.g., presence of nitrogen suggesting an alkaloid). When HR-MS data is ambiguous, ¹³C NMR signal count and integration can help validate the proposed formula [27].
Spectroscopic data act as the "code" that must be deciphered to reveal the molecular structure. Different spectroscopic techniques provide complementary layers of structural information, which the CASE system integrates to form a set of positive and negative constraints [26].
Table 2: Spectral Data Types and Their Informational Role in CASE
| Spectroscopic Technique | Key Data Provided | Role in Constraint Generation | Typical Input for Modern CASE |
|---|---|---|---|
| HR-MS | Accurate molecular mass, molecular formula, fragmentation patterns. | Defines the search space (MF). Fragments can suggest substructures [28]. | Molecular formula, key fragment m/z values. |
| ¹H & ¹³C NMR | Chemical shifts (δ), signal multiplicity, integration. | Reveals chemical environments, counts of CHₓ groups. Forms the basis for initial atom labeling. | Peak lists (δ, multiplicity) are essential. Processed spectra are used for database dereplication. |
| 2D NMR (HSQC, HMQC) | ¹H-¹³C direct (¹JCH) correlations. | Defines all protonated carbons (CH, CH₂, CH₃ groups). Creates a foundational connectivity map. | Peak pair lists (δH, δC) are mandatory inputs for structure assembly. |
| 2D NMR (COSY, TOCSY) | ¹H-¹H through-bond (²-³JHH) correlations. | Identifies spin systems and contiguous proton networks. | Correlation lists define proximity between hydrogen atoms. |
| 2D NMR (HMBC) | ¹H-¹³C long-range (²-³JCH) correlations. | Connects molecular fragments across quaternary centers and heteroatoms. Most critical for assembling the skeletal structure. | Correlation lists are the primary data for connecting substructures. |
| IR Spectroscopy | Characteristic functional group absorptions. | Identifies specific bond types (e.g., OH, C=O, C≡N). | Used as a filter to validate or reject candidate structures containing incompatible functional groups. |
Protocol 1: Spectral Data Preparation for a Classical CASE System (e.g., Sherlock/StrucEluc)
The structure generator is the core algorithmic component of a CASE system. Its function is to assemble all possible constitutional isomers that satisfy three conditions: 1) the input molecular formula, 2) any user-defined or automatically detected structural fragments, and 3) the connectivity constraints derived from 2D NMR correlations [32]. Generators employ advanced graph theory and combinatorial algorithms to navigate the immense isomer space efficiently.
Table 3: Taxonomy and Characteristics of Chemical Structure Generators
| Generator Type | Core Principle | Advantages | Limitations | Example Systems |
|---|---|---|---|---|
| Structure Assembly | Builds molecules bond-by-bond or fragment-by-fragment, starting from atoms or known substructures. | Intuitive; allows integration of spectral fragments early in the process. | Can suffer from combinatorial explosion for large, unconstrained molecules. | ASSEMBLE, GENOA, generators in CHEMICS [32]. |
| Structure Reduction (Orderly Generation) | Generates all possible adjacency matrices for the MF and filters out invalid graphs. Based on mathematical group theory. | Highly efficient and exhaustive; minimal memory overhead for canonical checking. | Less intuitive; harder to integrate intermediate spectral constraints during the generation process. | MOLGEN, MASS [32]. |
| Stochastic / Heuristic | Uses probabilistic methods (e.g., simulated annealing, genetic algorithms) to search the isomer space. | Can find solutions for very large molecules where exhaustive generation is impossible. | Not exhaustive; may miss the correct structure; requires careful tuning of parameters. | SENECA [32]. |
| AI-Based Generative | Uses deep learning models (e.g., Transformers) to directly predict the most probable structure from spectral data as an input-output sequence. | Extremely fast (seconds); learns complex spectral-structure relationships directly from data. | Requires large, high-quality training datasets; "black-box" nature can reduce interpretability. | CLAMS, other Transformer models [31]. |
Protocol 2: Structure Generation and Ranking Workflow
Emerging generative AI models like CLAMS represent a paradigm shift, replacing multi-step combinatorial workflows with a single end-to-end prediction [31].
Before de novo elucidation, scientists use databases to check if a compound is known, a process called dereplication. Advanced algorithms like VInSMoC now enable the discovery of structural variants [28].
Table 4: Key Software, Databases, and Tools for Modern CASE
| Tool/Resource Name | Type | Primary Function in CASE | Access / Reference |
|---|---|---|---|
| ACD/Structure Elucidator | Commercial CASE Suite | Integrated platform for processing spectra, generating MCDs, exhaustive structure generation, and ranking. A long-standing industry standard [26]. | Commercial |
| Sherlock | Open-Source CASE System | Provides a graphical workflow from peak picking to structure generation and ranking, emphasizing user control and traceability [30]. | Open Source [30] |
| GNPS (Global Natural Products Social Molecular Networking) | Public MS/MS Data Platform | Repository and ecosystem for experimental mass spectra. Enables dereplication, molecular networking, and variant searching via tools like VInSMoC [28]. | Open Access |
| Natural Products Atlas | Curated Structural Database | Open-access database of microbially-derived natural product structures. Serves as a critical reference for dereplication and training AI models [29]. | Open Access [29] |
| CLAMS & Similar AI Models | Generative AI Software | Proof-of-concept transformer models that directly predict molecular structures from spectroscopic data, offering extreme speed [31]. | Research Code [31] |
| MOLGEN | Chemical Graph Generator | A highly efficient, exhaustive structure generator based on orderly generation, used as a backend in some CASE systems [32]. | Commercial / Academic |
| PubChem / COCONUT | Large-Scale Compound Databases | Sources of millions of chemical structures used for large-scale database searches in mass spectrometry-based annotation [28]. | Open Access |
Computer-Assisted Structure Elucidation (CASE) represents a transformative paradigm in natural products research, systematically addressing the critical bottlenecks of dereplication and the determination of complex stereochemistry [33]. By integrating advanced spectroscopic data with computational algorithms, CASE systems accelerate the transition from raw analytical data to confident structural proposals. This application note details a standardized, instrument-agnostic workflow encompassing data preparation, automated peak picking, candidate structure generation, and probabilistic ranking, providing researchers with a reproducible framework for elucidating novel natural products [34] [35].
A successful CASE workflow begins with the selection of appropriate software and the acquisition of a foundational NMR dataset. The following tables summarize key platforms and the essential spectroscopic data required for de novo elucidation.
Table 1: Comparison of Representative CASE Software Platforms
| Software Platform | Core Functionality | Key Workflow Feature | Primary Application |
|---|---|---|---|
| ACD/Structure Elucidator Suite [34] | De novo structure generation, 3D configuration from NOESY/ROESY, database dereplication. | Automated Molecular Connectivity Diagram (MCD) generation and editing, real-time structure ranking. | Elucidation of complex, unknown natural products. |
| Mnova Structure Elucidation [35] | Integrated NMR processing and CASE in a single environment. | Six-step guided workflow from data input to structure ranking. | Streamlined elucidation for both experts and non-experts. |
| MS-DIAL / MZmine [36] | LC-MS/MS data processing, peak picking, and alignment for metabolomics. | Feature detection, decomposition, and identification. | Untargeted metabolomics profiling and dereplication. |
Table 2: Minimum Recommended NMR Data for CASE Analysis [34]
| Experiment Type | Information Provided | Role in CASE Workflow |
|---|---|---|
| ¹H NMR | Chemical shift, integration, coupling constants. | Defines proton count and local electronic environment. |
| ¹³C NMR | Chemical shift, multiplicity (DEPT). | Defines carbon count and hybridization (sp³, sp², sp). |
| COSY | Through-bond ¹H-¹H couplings (²J, ³J). | Establishes proton connectivity networks. |
| HSQC | One-bond ¹H-¹³C correlations. | Directly links protons to their bonded carbons. |
| HMBC | Long-range ¹H-¹³C correlations (²J, ³J). | Establishes linkages between structural fragments, crucial for assembling the carbon skeleton. |
Objective: To prepare and import standardized, high-quality spectral data into the CASE software.
Objective: To accurately identify cross-peaks in 2D spectra (HSQC, HMBC, COSY) which form the basis of structural constraints [36].
Objective: To algorithmically generate all plausible structures consistent with the data and identify the most probable candidate [34].
Table 3: Essential Software and Materials for CASE Workflow
| Item | Function/Description | Application Note |
|---|---|---|
| CASE Software Suite (e.g., ACD/SE, Mnova) [34] [35] | Integrated platform for data processing, structure generation, and ranking. | The core tool for executing the workflow; selection depends on lab preference and required features. |
| High-Resolution Mass Spectrometer | Provides accurate molecular formula. | Essential first step to constrain the structure generation problem. |
| NMR Spectrometer (≥ 400 MHz) | Generates the 1D and 2D correlation data. | A minimum set of ¹H, ¹³C, HSQC, HMBC, and COSY is recommended [34]. |
| Reference Compound (e.g., TMS) | Provides chemical shift reference (0 ppm). | Critical for accurate chemical shift alignment across all spectra. |
| Deuterated Solvent (e.g., CDCl₃, DMSO-d₆) | NMR solvent. | Choice affects chemical shifts and must be considered in prediction algorithms. |
| Fragment/Structure Database (e.g., PubChem, internal libraries) [34] | Aids in dereplication and provides fragments for MCD. | Used to avoid "rediscovering" known compounds and to seed the MCD with known substructures. |
Diagram 1: Standardized CASE Workflow for Natural Products
Diagram 2: Peak Picking and Validation Protocol
Within the discipline of natural products research, the unequivocal determination of molecular structure is paramount, as it defines biological activity and guides synthetic and medicinal chemistry efforts. Despite advancements in spectroscopic techniques, structural misassignment remains a persistent issue in the literature, underscoring the need for rigorous analytical methodologies [37]. This article details the construction and application of the Molecular Connectivity Diagram (MCD), a critical intermediate representation in Computer-Assisted Structure Elucidation (CASE) systems. The MCD operationalizes raw NMR correlation data into a set of explicit structural constraints, forming the foundational dataset from which all plausible chemical skeletons are generated [38].
The broader thesis posits that integrating CASE methodologies into the natural product discovery workflow is essential for enhancing accuracy, efficiency, and reproducibility. The evolution of NMR from a tool for analyzing pure compounds to one capable of direct mixture analysis (e.g., via DOSY, STOCSY) further amplifies the need for robust computational frameworks to manage complexity [39]. The MCD sits at the heart of this integration, translating ambiguous spectral peaks into a logical map of atom-to-atom connections.
The MCD is built from a core set of one- and two-dimensional NMR experiments. Accurate interpretation of these spectra is a prerequisite for generating a reliable MCD.
A standard suite of experiments provides the necessary data for basic structure elucidation [38].
Table 1: Core NMR Experiments for MCD Generation
| Experiment | Nuclei Correlated | Key Structural Information Provided | Typical Constraint in MCD |
|---|---|---|---|
| ¹H NMR | -- | Chemical shift (δ), integration (H count), multiplicity (neighbors) [40] [41]. | Defines hydrogen atoms and their local environments. |
| ¹³C NMR | -- | Chemical shift (δ), identifies number of unique carbons. | Defines carbon atom types (C, CH, CH₂, CH₃). |
| HSQC (or HMQC) | ¹H→¹³C (one-bond) | Directly pairs each proton to its bonded carbon atom. | Crucial: Defines the heavy atom (C, N, O) skeleton with attached hydrogens. |
| COSY | ¹H→¹H (2-3 bonds) | Identifies protons that are coupled to each other through 2-3 bonds (geminal or vicinal). | Establishes connectivities between protonated atoms (e.g., CH-CH). |
| HMBC | ¹H→¹³C (2-4 bonds) | Correlates protons to carbons separated by 2-4 bonds (including long-range). | Establishes key linkages between structural fragments, often across heteroatoms or quaternary carbons. |
Each peak in a 2D spectrum represents a correlation between two nuclei. The MCD creation process involves translating these correlations into connectivity rules [38]:
The following protocol details the steps for transforming processed NMR spectra into a refined MCD suitable for structure generation in a CASE system [38] [42].
Diagram 1: MCD Construction Workflow (85 characters)
This interactive step is where researcher expertise is critical [38] [42].
Once a validated MCD exists, the CASE system uses it to generate and rank all possible structural isomers.
Diagram 2: MCD to Validated Structure (80 characters)
Table 2: Essential Tools for CASE and MCD-Based Elucidation
| Tool Category | Specific Item / Software | Function in MCD Workflow | Key Considerations |
|---|---|---|---|
| NMR Experiments | HSQC, HMBC, COSY | Provide the essential ¹H-¹³C and ¹H-¹H connectivity data. | Quality of 2D data is the primary limiting factor for MCD accuracy. |
| CASE Software | ACD/Structure Elucidator [38], Bruker CMC-se [42], MNova Structure Elucidation | Platform for creating, editing the MCD, and generating/ranking structures. | Differ in user interface, algorithm speed, and handling of non-standard correlations. |
| NMR Prediction Engines | HOSE Code Algorithms [38], Neural Networks, DFT (GIAO) | Provide the predicted chemical shifts used to rank candidate structures. | Speed vs. Accuracy trade-off: HOSE/Neural nets (fast) for ranking, DFT (slow, accurate) for final validation. |
| Machine Learning & AI | ShiftML, IMPRESSION [44] | ML models trained on quantum-chemical data predict NMR shifts at near-DFT accuracy with drastically reduced compute time. | Represents the cutting edge for accelerating the prediction and validation cycle [44]. |
| Data Format & Exchange | NMReData Initiative [42] | Standardized format for reporting and sharing NMR assignments and correlations. | Promotes reproducibility and allows for the creation of shared, high-quality spectral databases. |
The Molecular Connectivity Diagram is the indispensable conceptual and computational bridge between experimental NMR correlations and the chemical structure of an unknown natural product. By following standardized protocols for MCD construction and refinement, researchers can leverage CASE systems to exhaustively and objectively generate all plausible structures consistent with the data, thereby minimizing the risk of misassignment. As the field advances with machine learning and automated workflows, the MCD will remain the fundamental representation ensuring that computational power is effectively guided by, and accountable to, experimental spectroscopic evidence.
The structure elucidation of complex natural products remains a formidable challenge in chemical research. Nuclear Magnetic Resonance (NMR) spectroscopy is the definitive analytical tool for this task, but its interpretation is often non-trivial and prone to error [37]. Computer-Assisted Structure Elucidation (CASE) systems have emerged as indispensable partners to the spectroscopist, transforming raw spectral data into probable chemical structures. A critical bottleneck in this pipeline has been the reliance on sparse experimental NMR reference libraries. For known natural products, fewer than 7% have experimentally assigned NMR spectra available in databases [45].
This gap is bridged by in silico chemical shift prediction. Within a broader thesis on advancing CASE for natural products research, the integration of high-accuracy prediction algorithms represents a paradigm shift. These algorithms enable the creation of vast, virtual spectral libraries and provide a robust, quantitative metric for ranking computer-generated structural candidates against experimental data. Modern approaches, leveraging machine learning (ML) and quantum mechanics, have moved prediction accuracy from a heuristic aid to a reliable computational assay [44]. This document details the application notes and experimental protocols for employing these algorithms in a contemporary CASE workflow, focusing on the critical steps of structure generation and candidate ranking to achieve confident and efficient structural determinations.
Chemical shift prediction methodologies have evolved from empirical rules to sophisticated data-driven models. The performance of these algorithms, measured by the mean absolute error (MAE) between predicted and experimental shifts, directly impacts their utility in discriminating between similar structural candidates.
Table 1: Performance Comparison of Contemporary Chemical Shift Prediction Methods
| Method (Algorithm) | Type | Key Features | Reported MAE (¹H) | Reported MAE (¹³C) | Primary Application Context |
|---|---|---|---|---|---|
| PROSPRE [45] | ML (Graph Neural Network) | "Solvent-aware"; trained on curated experimental data; transfer learning. | < 0.10 ppm | Not specified (¹³C upcoming) | Small molecules in solution (H₂O, CDCl₃, DMSO, MeOD). |
| CSTShift [46] | Hybrid 3D-GNN/DFT | Incorporates DFT-calculated shielding tensor descriptors; uses 3D molecular geometry. | 0.185 ppm | 0.944 ppm | Small organic molecules; excels with 3D conformational data. |
| UCBShift [47] | Hybrid (Transfer Learning + Random Forest) | Combines sequence/structure alignment with feature-based ML; robust to outliers. | 0.31 ppm (amide H) | 0.81-1.81 ppm (Cα, Cβ, C', N) | Proteins and biological macromolecules. |
| HOSE Code-Based [45] [48] | Empirical (Similarity) | Hierarchical Ordered Spherical description of Environment; lookup of similar substructures. | 0.2 – 0.3 ppm | ~1.7 – 3.8 ppm | Small molecules, rapid prediction for common fragments. |
| DFT/GIAO (B3LYP) [46] | Quantum Mechanical | Ab initio density functional theory calculations; considered a high-accuracy benchmark. | ~0.2 – 0.4 ppm | ~2.0 – 4.0 ppm | Small to medium molecules; high computational cost. |
| ShiftML/IMPRESSION [44] | ML (Gaussian Process / Neural Network) | Trained on DFT-calculated shifts for solids/liquids; bypasses experimental database errors. | ~0.49 ppm | ~4.3 ppm | Molecular crystals (ShiftML) & solution-state (IMPRESSION). |
The evolution is clear: modern ML and hybrid models like PROSPRE and CSTShift now match or surpass the accuracy of traditional DFT at a fraction of the computational time, making them feasible for high-throughput ranking of thousands of candidate structures [45] [46]. The choice of algorithm depends on the molecular system (small molecule vs. protein), the availability of 3D conformational data, and the required balance between speed and ultra-high accuracy.
This protocol outlines the end-to-end process for elucidating an unknown natural product using a CASE system augmented by predictive ranking.
Objective: To generate all plausible structural isomers consistent with 2D NMR data and identify the single best candidate through quantitative chemical shift comparison.
Input Requirements:
Procedure:
Structure Generation:
Chemical Shift Prediction & Ranking:
Validation & Reporting:
Diagram: Computer-Assisted Structure Elucidation (CASE) workflow integrating chemical shift prediction for candidate ranking.
This protocol is for research groups aiming to develop or fine-tune a chemical shift predictor for a specific family of natural products (e.g., flavonoids, terpenoids) where general models may lack sufficient training data.
Objective: To create a specialized prediction model with optimized accuracy for a target chemical space by leveraging both public data and private experimental measurements.
Input Requirements:
Procedure:
Model Selection & Architecture:
Training & Optimization:
Evaluation & Deployment:
Diagram: Architecture of a hybrid chemical shift prediction model combining multiple algorithmic approaches.
Table 2: Essential Digital Tools & Resources for CASE with Chemical Shift Prediction
| Tool/Resource | Type | Primary Function in Workflow | Key Utility |
|---|---|---|---|
| ACD/Structure Elucidator | Commercial Software Suite | Automated structure generation from NMR data. | Integrates prediction and ranking; industry-standard platform [37]. |
| CENSA | CASE Program | Structure elucidation using 1D/2D NMR data. | Handles complex natural products with few protons [37]. |
| PROSPRE [45] | Web-based Predictor | Predicts ¹H shifts for submitted structures (SMILES/SDF). | High accuracy (<0.10 ppm MAE); accounts for solvent effects. |
| NMRShiftDB2 / NP-MRD [45] | Open-Access Database | Repository of experimental NMR data for organic molecules & natural products. | Source for training data and experimental comparisons; <7% coverage of known NPs [45]. |
| RDKit | Open-Source Cheminformatics | Python library for molecule manipulation and descriptor calculation. | Essential for preprocessing structures, generating conformers, and building custom ML pipelines [46] [48]. |
| Gaussian / ORCA | Quantum Chemistry Software | Performs DFT calculations for geometry optimization and NMR shielding. | Provides benchmark-quality shifts and shielding tensors for hybrid models like CSTShift [46]. |
| PyTorch / TensorFlow | ML Frameworks | Libraries for building and training neural network models. | Used to develop and deploy custom graph neural network predictors [46] [48]. |
Integrating predictive algorithms into a CASE workflow requires careful consideration. Data quality is paramount: the "garbage in, garbage out" principle applies fully. Inconsistent referencing or incorrect solvent specification in training data can cripple a model's accuracy [45]. Computational cost must be balanced against project needs. While HOSE codes are instantaneous and DFT is computationally intensive, modern ML models like PROSPRE offer a near-optimal balance for high-throughput ranking [45].
The future lies in increasingly integrated and intelligent systems. We will see tighter coupling between ab initio structure generators and predictors that provide real-time feedback to constrain the search space. The rise of generative AI models could invert the process, proposing novel structures that perfectly match an experimental NMR spectrum. Furthermore, the expansion of FAIR (Findable, Accessible, Interoperable, Reusable) databases like NP-MRD will provide the high-quality, solvent-specific data needed to train the next generation of ultra-accurate, chemistry-aware predictors [45]. For the natural products researcher, these advances promise to transform structure elucidation from a time-consuming puzzle into a more streamlined, confident, and discovery-focused process.
The structural elucidation of complex natural products remains a formidable challenge in chemical and pharmaceutical research. Despite advances in spectroscopic techniques, a disturbing number of incorrect structures continue to be reported in the literature, often due to the inherent complexity of these molecules and the subjective interpretation of spectral data [37]. Computer-Assisted Structure Elucidation (CASE) has emerged as an indispensable framework to minimize this risk by systematically generating all chemically plausible structures consistent with experimental data and ranking them probabilistically [37]. Within a broader thesis on CASE, this article details practical protocols and application notes, demonstrating how integrated computational workflows are transforming the accuracy, speed, and scalability of natural product structure determination and revision.
The evolution of CASE now extends beyond traditional rule-based systems. The field is being reshaped by the integration of high-throughput spectral data with advanced algorithms for molecular networking, database mining, and machine learning. These approaches address core challenges such as the presence of long-range correlations in NMR, the identification of novel molecular variants, and the dereplication of known compounds [50] [28]. The following sections provide researchers with actionable methodologies and a critical analysis of tools for applying CASE to real-world problems in natural product research and drug development.
Modern CASE systems are built on core computational principles that transform raw spectral data into reliable structural hypotheses. A key foundation is the generation of all possible structural isomers within user-defined constraints (e.g., molecular formula, substructure presence/absence) that satisfy the observed spectroscopic correlations [37]. The process typically utilizes 2D NMR data—such as COSY and HMBC correlations—with an initial assumption that correlations represent atoms connected by no more than three bonds, though algorithms must account for longer-range correlations to avoid errors [37].
The performance of different CASE strategies can be quantitatively evaluated. Benchmarking studies reveal the effectiveness of various algorithmic approaches, as summarized in the table below.
Table 1: Performance Benchmarks of Contemporary CASE and Spectral Analysis Algorithms
| Algorithm/Approach | Core Function | Reported Performance Metric | Key Advantage |
|---|---|---|---|
| Traditional HSQC Lookup [50] | Spectral similarity search via modified Hungarian distance metric. | Recovers ~70-80% of structural similarity; efficiency plateaus with library size. | Establishes baseline for NMR-based dereplication. |
| NMR Molecular Networking [50] | Transitive annotation propagation across HSQC spectral networks. | Enables dereplication and accelerates unknown identification in case studies. | Leverages spectral relationships for scalable annotation. |
| Algorithmic Molecular Networking [50] | Integrates graph topology metrics to correct spectral rankings. | Reduces false positives and improves ranking efficiency. | Uses network structure to enhance reliability. |
| VInSMoC (MS/MS Search) [28] | Database search for molecular variants with statistical significance. | Identified 43,000 knowns & 85,000 unreported variants from 483M spectra. | Enables discovery of novel variants beyond exact matching. |
The transition from standalone structure generators to integrated, data-rich workflows represents the current paradigm. As shown in Table 1, newer methods like NMR molecular networking and variant-tolerant MS/MS search focus on leveraging large-scale spectral relationships and probabilistic scoring, moving beyond simple library lookup [50] [28]. This shift addresses the critical need to identify both known compounds and novel structural classes efficiently within complex metabolomic mixtures.
Background & Objective: This protocol addresses the challenge of dereplicating known compounds and elucidating novel analogues within a series of related natural product fractions using 2D NMR data. Traditional methods struggle with spectral ambiguity and long-range correlations [37]. The workflow leverages the principles of NMR molecular networking, which applies transitive annotation and graph-based metrics to improve accuracy [50].
Experimental Protocol:
Data Acquisition & Preprocessing:
Spectral Distance Calculation & Network Construction:
Annotation Propagation & Dereplication:
Algorithmic Ranking for Novel Analogues:
Validation: Confirm the top-ranked structure through complementary data (e.g., HMBC, COSY) and/or by comparison of predicted vs. observed chemical shifts using quantum mechanical calculations (e.g., DFT).
The Scientist's Toolkit for NMR-Based CASE:
The following diagram illustrates the logical workflow and decision points in this NMR-based structure elucidation protocol.
Background & Objective: Mass spectrometry-based metabolomics generates vast datasets where the goal is to identify not only exact matches to known compounds but also structural variants and novel analogues. This protocol utilizes the VInSMoC (Variable Interpretation of Spectrum–Molecule Couples) algorithm to search experimental MS/MS spectra against large molecular databases in a modification-tolerant manner, facilitating the discovery of new natural product variants [28].
Experimental Protocol:
LC-MS/MS Data Acquisition:
Spectral Processing and Database Curation:
VInSMoC Database Search:
Analysis of Results and Putative Pathway Mapping:
Validation: Prioritize high-confidence variant hits for isolation (e.g., using preparative HPLC) and subsequent definitive structure elucidation by NMR, following the protocol in Application Note 1.
The Scientist's Toolkit for MS-Based CASE:
The workflow for this MS-centric approach is depicted in the following diagram.
The most powerful applications of CASE involve the strategic integration of NMR and MS data. An integrated workflow might begin with LC-MS/MS analysis and VInSMoC screening to rapidly dereplicate and highlight novel variants. Subsequently, promising, non-dereplicated variants are purified, and their structures are conclusively elucidated using the detailed, NMR-based CASE protocol. This synergy maximizes throughput while ensuring definitive structural proof.
Future advancements in CASE will be driven by deeper integration of machine learning for spectral prediction and scoring, the expansion of open, high-quality spectral databases, and the development of unified platforms that seamlessly combine NMR, MS, and genomic data [50] [28]. For researchers, adopting these protocols mitigates the risk of miselucidation and transforms the structure determination process from a bottleneck into a robust, data-driven engine for natural product discovery and drug development [37].
The structure elucidation of natural products, particularly novel or trace compounds, remains a formidable analytical challenge. Traditional reliance on nuclear magnetic resonance (NMR) spectroscopy, while powerful, can be impeded by factors such as limited sample quantity, compound complexity, or the presence of stereochemical ambiguities. Within this context, Computer-Assisted Structure Elucidation (CASE) has emerged as a critical framework, systematically leveraging computational power to interpret spectroscopic data and generate structurally consistent candidates [37]. The evolution of CASE now extends beyond the traditional core of 1D/2D NMR to embrace a holistic, multi-technique integration.
This article details the advanced integration of Mass Spectrometry (MS), Infrared Spectroscopy (IR), and Density Functional Theory (DFT) calculations into the CASE workflow. This paradigm shift is driven by the need to solve structures from sub-microgram quantities of material, where classical isolation and extensive NMR study are impossible [51]. MS provides molecular formula and fragment-based structural clues, IR delivers definitive functional group and bonding information, and DFT calculations serve as a powerful validator, predicting spectroscopic properties for candidate structures with high accuracy. Together, they form a complementary triad that can deliver unambiguous structural identification, as exemplified by the discovery of the salinilactones, a new class of volatile bicyclic lactones from marine bacteria [51]. This integrated approach minimizes the risk of misassignment—a persistent issue in natural products research [37]—and streamlines the path from detection to confident identification.
The synergy between MS, IR, and DFT is rooted in the orthogonal information each technique provides. The workflow is iterative and hypothesis-driven, moving from broad characterization to precise validation.
Mass Spectrometry (MS) for Molecular Blueprinting: High-resolution mass spectrometry (HR-MS) is the entry point, delivering the exact molecular formula (e.g., C₁₀H₁₄O₃) and calculating the number of double bond equivalents (DBEs) [51]. Tandem MS (MS/MS) fragmentation patterns reveal skeletal features and key functional groups. For instance, characteristic ions from McLafferty rearrangements can indicate specific acyl side chains [51].
Infrared (IR) Spectroscopy for Functional Group Interrogation: Solid-phase Gas Chromatography/IR (GC/IR) provides high-sensitivity, chromatographically-resolved IR spectra [51]. This yields direct evidence of functional groups through their signature stretching vibrations (e.g., carbonyls at ~1700-1800 cm⁻¹). Critically, IR can confirm or rule out structural features suggested by MS, such as distinguishing between ester and ketone carbonyls or confirming the absence of C=C double bonds [51].
Density Functional Theory (DFT) for In Silico Validation: DFT calculations bridge the gap between proposed chemical structures and observed experimental data. For a set of candidate structures consistent with MS and IR data, DFT is used to:
The power of this integrated approach is demonstrated in the identification of salinilactones A–C from Salinispora bacteria [51]. With only nanogram quantities available, a traditional structure elucidation was not feasible.
1. Initial Profiling (GC/MS & GC/IR): Analysis of bacterial volatiles revealed three unknown compounds with shared characteristic MS fragments at m/z 140 and 122, suggesting a common core [51]. HR-MS established the molecular formula for the major component (Salinilactone B) as C₁₀H₁₄O₃ (4 DBEs). GC/IR showed two distinct carbonyl stretches: a ketone (1696 cm⁻¹) and a high-energy ester (1769 cm⁻¹), the latter indicating ring strain. No C=C stretch was observed [51].
2. Hypothesis Generation & DFT Screening: The data (4 DBEs, two carbonyls, no alkenes) pointed to a bicyclic lactone system. Several isomeric [3.1.0]-bicyclic structures were plausible [51]. Instead of synthesizing all possibilities, dispersion-corrected DFT calculations (B3LYP-D/6-311G(p,d)) were employed to simulate the IR spectra of the candidate isomers. Visual and algorithmic comparison of the calculated versus experimental IR fingerprint regions unambiguously identified the correct structure [51].
3. Synthesis and Absolute Configuration: The DFT-prioritized structure was successfully synthesized, and its MS, IR, and chromatographic properties matched the natural product [51]. Asymmetric synthesis and chiral GC/MS further determined the absolute configuration of the natural enantiomer as (1R,5S) [51].
Table 1: Summary of Analytical Data for Salinilactone B Elucidation [51]
| Analytical Technique | Key Data Obtained | Structural Information Revealed |
|---|---|---|
| GC/HR-MS | m/z 182.0972 [M]⁺ | Molecular Formula: C₁₀H₁₄O₃ |
| MS Fragmentation | m/z 140, 122, 153, 125 | C5 acyl side-chain; fragmentation pattern consistent with γ-lactone core. |
| Solid-Phase GC/IR | Stretches at 1769 cm⁻¹ and 1696 cm⁻¹ | Presence of a strained ester and a ketone carbonyl group. |
| No absorption ~1620-1680 cm⁻¹ | Absence of carbon-carbon double bonds. | |
| DFT Calculation (B3LYP-D) | Simulated IR spectrum of candidate 8 | Best match to experimental IR spectrum; structure selected for synthesis. |
Table 2: Key Research Reagents and Materials for Integrated MS/IR/DFT Analysis
| Item | Function in Analysis | Specific Application Notes |
|---|---|---|
| Closed-Loop Stripping (CLSA) Apparatus | Pre-concentrates trace volatile organic compounds from liquid or air samples for analysis. | Essential for preparing samples from bacterial cultures or environmental sources for GC-based techniques [51]. |
| Solid-Phase GC/IR Interface | Enables high-sensitivity, flow-through IR detection of GC eluents. Provides chromatographically resolved IR spectra. | Critical for obtaining functional group data on nanogram-scale components in complex mixtures [51]. |
| Deuterated Internal Standards (e.g., d₂-8) | Used in isotope dilution methods for absolute quantification of target analytes in complex matrices. | Allows accurate measurement of natural product titers directly from culture extracts [51]. |
| DFT Software with Dispersion Correction | Performs quantum mechanical calculations to optimize molecular geometry and predict spectroscopic properties. | Functionals like B3LYP-D and basis sets like 6-311G(p,d) are recommended for accurate IR simulation [51]. Modern GPU-accelerated cloud platforms can drastically reduce computation time [52]. |
| Chiral GC Stationary Phases | Enables separation of enantiomers by gas chromatography. | Required for determining the absolute configuration of chiral natural products by comparison with synthesized enantiomers [51]. |
Application: Profiling volatile organic compounds from microbial cultures. Steps:
Application: Selecting the most probable structure from a set of isomers. Steps:
Application: Confirming identity and determining absolute configuration. Steps:
Integrated MS/IR/DFT Workflow for CASE
Proposed Biosynthetic Relationship of Salinilactones [51]
The structure elucidation of natural products is a foundational pillar of modern drug discovery. However, this process encounters significant bottlenecks when dealing with proton-deficient scaffolds—complex molecular frameworks with low hydrogen density—and truly novel chemotypes for which no close structural analogs exist. These challenges are amplified within the context of Computer-Assisted Structure Elucidation (CASE), where algorithmic logic depends heavily on the quality, quantity, and interpretability of input spectroscopic data [23] [53].
Proton-deficient compounds, such as highly conjugated polyketides, glycosylated flavonoids with many quaternary carbons, or novel aromatic heterocycles, yield information-sparse 1H NMR spectra. The scarcity of protons reduces the number of observable through-bond correlations (e.g., in COSY and TOCSY experiments) and weakens key proton-detected heteronuclear signals (e.g., in HMBC spectra), creating an underdetermined system for structural assembly [54] [53]. Simultaneously, ambiguity arises from dynamic phenomena common in natural products, including tautomerism, intramolecular hydrogen bonding, and pH-dependent protonation states, which can lead to variable or averaged spectroscopic signals that misrepresent the true, bioactive structure [54] [55].
This article details practical protocols and strategies to manage these data limitations. It frames the discussion within the broader thesis that advancing CASE requires not just more powerful algorithms, but a refined, synergistic workflow integrating targeted experimental spectroscopy, intelligent data pre-processing, and computational modeling to resolve ambiguity where traditional data falls short.
The following strategies are designed to systematically overcome the informational gaps presented by challenging scaffolds.
When standard 1H-13C correlation experiments are insufficient, a targeted suite of advanced NMR experiments is required.
1. Prioritize Long-Range Heteronuclear Correlation Experiments:
2. Utilize Deuterium Isotope Effects to Probe Exchangeable Protons and Tautomerism:
3. Implement Quantitative 2J/3J Coupling Constant Analysis:
Table 1: Advanced NMR Experiments for Resolving Structural Ambiguity
| Experiment | Key Information | Target Use Case | Limitation |
|---|---|---|---|
| 1,n-ADEQUATE | Direct C-C connectivity via 1JCC [54]. | Tracing backbone in polycycles with quaternary carbons. | Very low sensitivity; requires high sample concentration. |
| HMBC with D2O | Identifies correlations to exchangeable protons; clarifies ambiguous long-range peaks. | Confirming N/O-methylation sites or involvement of NH/OH in hydrogen bonds. | Signal loss for protons exchanged with deuterium. |
| Deuterium Isotope Effect | Detects hydrogen bonding and maps electron density changes upon H/D exchange [54]. | Determining tautomeric states, strength of intramolecular H-bonds. | Requires careful measurement of small Δδ (ppb). |
| HSQC-TOCSY | Extends connectivity from a directly bonded 1H-13C pair to the entire proton spin system. | Unraveling overlapped sugar or amino acid spin systems in proton-rich regions. | Limited utility in proton-deficient core regions. |
The performance of a CASE system is directly contingent on the constraints provided. Strategic input is crucial for novel scaffolds [53].
1. Curating the "Fuzzy" Constraint List from Ambiguous HMBC Data:
2. Defining "Must-Have" and "Unknown" Fragments from Prior Knowledge:
Table 2: Performance Metrics of a CASE System (ACD/Structure Elucidator) in Blind Trials [53]
| Trial Category | Number of Challenges | Success Rate | Average Processing & Elucidation Time | Key Challenge Types |
|---|---|---|---|---|
| Double/Single Agreement | 100 | 89% | ~84 minutes | Large heteroatom count, symmetry, poor data. |
| Double-Blind Trials | 10 | Not separately quantified | Similar to average | Complete unknown to both submitter and analyst. |
| Incorrect/Rejected | 12 | - | - | Data inadequate (poor S/N, impurities) or molecular size >1000 Da (in early software versions). |
Artificial Intelligence, particularly deep neural networks (DNNs), is moving beyond dereplication to actively assist in the elucidation of novel scaffolds [24].
Strategy: Multi-Model Consensus Prediction.
For scaffolds where biological activity depends on a specific protonation state or tautomeric form, static structure elucidation is insufficient [55].
Procedure: MD-Guided Determination of Bioactive Conformers.
Table 3: Research Toolkit for Managing Data Ambiguity
| Category | Item/Resource | Function | Example/Note |
|---|---|---|---|
| Chemical Reagents | Deuterium Oxide (D2O) | Identifies exchangeable protons, clarifies spectra, measures isotope effects [41] [54]. | Add a drop to NMR sample to exchange OH/NH; suppresses water peak. |
| Chiral Solvating Agents (e.g., Pirkle's alcohol) | Helps assign absolute configuration or resolve enantiomeric signals in novel scaffolds. | Useful when novel scaffold contains a newly formed chiral center. | |
| NMR & Data Software | ACD/Structure Elucidator | Commercial CASE suite for structure generation from spectral constraints [53]. | Used in blind trials; averages ~84 min. for elucidation [53]. |
| MestReNova, TopSpin | Standard for NMR processing, peak picking, and preparing data for CASE input. | Accurate peak picking is critical for generating reliable constraints. | |
| Gaussian, ORCA | Software for Density Functional Theory (DFT) calculations of NMR chemical shifts. | Final validation by comparing calculated vs. experimental 13C shifts [54]. | |
| Modeling & AI Software | Schrödinger Suite, MOE | For MD simulations, protonation state sampling, and docking studies [55]. | Determines bioactive protonation state and conformation. |
| Specialized AI Models | DNNs for target prediction, spectra prediction, and generative scaffold design [24]. | Emerging tools to guide CASE and predict activity early. | |
| Databases | CAS Content Collection, NuBBE | Curated databases for dereplication and training AI models [24]. | Essential to avoid rediscovering known compounds. |
Effectively managing insufficient and ambiguous data in the elucidation of proton-deficient and novel scaffolds requires a paradigm shift from linear analysis to an integrated, cyclical workflow. The future of CASE in natural products research lies in tighter, real-time feedback loops between experiment and computation. Promising directions include the development of CASE systems that actively suggest the next most informative NMR experiment to run based on preliminary data analysis, and the broader integration of X-ray crystallographic data or cryo-EM density maps of natural product-protein complexes as direct structural constraints. Furthermore, as AI models trained on expansive, curated datasets like the CAS Content Collection become more sophisticated [24], their role will evolve from passive assistants to proactive partners in proposing structurally novel, yet biophysically plausible, scaffolds that push the boundaries of natural product-inspired drug discovery.
Within the broader thesis of Computer-Assisted Structure Elucidation (CASE) for natural products research, the expert interpretation of 2D NMR data stands as the critical, rate-limiting step. The isolation of novel bioactive compounds from nature routinely yields complex molecular architectures whose structural puzzles cannot be solved by library matching. Here, CASE systems function as indispensable force multipliers, transforming spectral data into definitive chemical structures with high efficiency and reliability [57]. The core challenge—and the focus of this document—is managing the uncertainty inherent in spectral interpretation, particularly 'non-standard' NMR correlations and incomplete structural constraints.
Modern CASE expert systems, such as the widely cited Structure Elucidator (StrucEluc), are engineered to overcome the historical bottleneck of the "combinatorial explosion." For a typical natural product molecular formula, the number of possible structural isomers can be on the order of Avogadro's number (10²³) [57]. Traditional approaches are computationally intractable. CASE systems invert this problem by using spectroscopic data as a filter. They generate a constrained set of candidate structures that satisfy all experimental observations, most importantly the network of through-bond correlations from experiments like COSY, HSQC, and HMBC [57] [58].
The most significant advancement in this field has been the shift from 1D to 2D NMR data as the primary input. While 1D spectra provide chemical shifts, 2D correlations map the molecular skeleton's connectivity. However, a persistent complication is the presence of 'non-standard' correlations—typically HMBC correlations that span more than three bonds ('long-range') or appear with unexpected intensity. These can arise from special conformational or electronic effects and, if misidentified as standard two- or three-bond correlations, will lead the elucidation to an impasse or an incorrect structure [57] [59].
To address this, contemporary CASE methodologies incorporate Fuzzy Structure Generation (FSG). FSG algorithms do not require the spectroscopist to know a priori which correlations are non-standard or their exact length [57] [58]. Instead, the system allows for a user-defined degree of "fuzziness" in the connectivity data. It then performs structure generation under the hypothesis that a certain number of correlations in the input table may be non-standard, efficiently navigating the vast structural space to identify all plausible candidates that satisfy both the definite and the ambiguous constraints. This approach has proven decisive in the structure revision of natural products, where published data often contains such ambiguities [58].
The following table summarizes quantitative performance data from recent applications, illustrating the efficiency and resolving power of CASE methodologies.
Table 1: Performance Metrics of CASE in Representative Structure Revisions and Elucidations [58] [31]
| Compound / System | Key Challenge | CASE Method Applied | Structures Generated (k) | Time to Solution | Key Metric / Outcome |
|---|---|---|---|---|---|
| Macahydantoin B (Revision) | Ambiguous HMBC correlations; published structure incorrect. | Fuzzy Structure Generation (FSG), limiting non-std. correlations to 1. | 1,987 → 124 ranked | 6 seconds | Correct structure identified as top rank (DP4A probability >99.99%). |
| Clionastatin A (Verification) | Complex polyhalogenated steroid; need for structural validation. | Molecular Connectivity Diagram (MCD) analysis & exhaustive structure generation. | Not Specified | Minutes | Confirmed published structure as unique solution fitting all NMR data. |
| Traditional CASE Workflow (Theoretical) | Navigating combinatorial isomer space for a ~50-atom molecule. | Fragment-based generation, spectral filtering. | 10¹⁰ – 10²⁰ (theoretical isomer space) | Minutes to Hours | Drastically reduces candidates to a manageable ranked list. |
| CLAMS AI Model (Benchmark) | Accelerating elucidation for small organic molecules. | Transformer-based encoder-decoder (spectra-to-SMILES). | Direct generation (no combinatorial list) | Seconds | Top-15 accuracy of 83% for molecules ≤ 29 atoms. |
This protocol details the process for using Fuzzy Structure Generation within a CASE system to elucidate a novel natural product when the 2D NMR data contains ambiguous or suspected non-standard correlations.
n) to be considered [58].n): If the MCD shows minor contradictions, start with n=1 or 2. For highly complex or messy spectra, a higher n may be required. The goal is to find the smallest n that yields chemically plausible structures.n correlations from the input list are allowed to be of non-standard length. It uses efficient graph theory algorithms to assemble structures from fragments and free atoms that satisfy all other definite constraints [57].
Diagram 1: Fuzzy Structure Generation (FSG) Workflow for CASE (77 characters)
The future of CASE lies in transcending purely logic- and rule-based systems through deep integration with Artificial Intelligence (AI). The next evolution is moving from assisted elucidation to anticipatory science, where AI models mimic the holistic reasoning of an expert natural products chemist [60].
1. Generative AI Models: New architectures, such as transformer-based encoder-decoder models, are challenging the traditional CASE workflow. Systems like CLAMS treat spectroscopic data (IR, UV, 1H NMR concatenated as a 1D array) as an input "language" and directly generate the molecular structure (as a SMILES string) as an output "translation" [31]. This end-to-end approach bypasses the combinatorial generation and filtering steps, offering solution times of seconds with promising accuracy for small molecules. While currently best-suited for less complex structures, this represents a paradigm shift towards direct spectral interpretation by AI.
2. Knowledge Graphs for Causal Inference: A major limitation in applying AI to natural products is the fragmented, multimodal nature of the data (genomics, metabolomics, bioassay results, published literature). The proposed solution is the construction of a federated Natural Product Science Knowledge Graph [60]. In this graph, nodes represent entities (e.g., a compound, a spectral peak, a gene cluster, a biological activity), and edges represent relationships (e.g., "compound A produces spectrum B," "gene cluster X biosynthesizes compound Y"). Such a structure organizes disconnected data into a machine-readable web of knowledge.
An AI model trained on this knowledge graph can perform causal inference, not just pattern recognition. For example, it could anticipate the structure of an unknown metabolite by reasoning across linked nodes: from a microbial genome (node) to a predicted biosynthetic gene cluster (edge) to a known chemical scaffold (node) to a predicted mass fragmentation pattern (edge) [60]. This mimics the logical deduction of a human expert connecting disparate pieces of evidence.
Diagram 2: Integrated AI and CASE Framework (68 characters)
Table 2: Key Research Reagent Solutions for Advanced CASE Workflows
| Tool / Reagent Category | Specific Examples | Function in CASE Workflow |
|---|---|---|
| Expert System Software | ACD/Structure Elucidator Suite [61] [58], StrucEluc [57] | Core platform for data input, MCD creation, fuzzy structure generation, and candidate ranking via empirical NMR prediction. |
| Quantum Chemical Computation Software | Gaussian, ORCA, CFOUR | Performs DFT calculations to predict highly accurate NMR chemical shifts and coupling constants for final structure validation and stereochemistry assignment [58]. |
| Spectral Databases & Predictors | ACD/NMR Predictors [59], CSEARCH [59], PubChem [61] | Provides libraries of known spectra for dereplication and robust algorithms (HOSE, neural networks) for rapid chemical shift prediction of candidate structures. |
| Generative AI & ML Tools | CLAMS-like transformer models [31], DP4-AI [31] | Offers alternative, ultra-fast elucidation pathways for suitable molecules and provides statistical probability measures for candidate selection. |
| Knowledge Graph Resources | LOTUS Initiative (Wikidata) [60], Experimental NP Knowledge Graph (ENPKG) [60] | Federated, structured databases connecting chemical, biological, and spectroscopic data to fuel next-generation, anticipatory AI models. |
| qNMR Standards | High-purity internal standards (e.g., maleic acid, 1,4-bis(trimethylsilyl)benzene) [62] | Enables quantitative NMR for assessing sample purity, crucial for obtaining accurate integral and intensity data for structure generation. |
Within the framework of computer-assisted structure elucidation (CASE) for natural products, the adage "garbage in, garbage out" is profoundly consequential. The successful identification of novel bioactive compounds hinges on the integrity of the spectral data input and the chemical relevance of the fragment libraries used for reasoning [34] [26]. This document details essential protocols and application notes to optimize the preparatory stages of the CASE workflow. Focusing on rigorous peak picking, robust data processing, and the strategic use of natural product-derived fragment libraries, these practices are designed to enhance the accuracy, efficiency, and reliability of de novo structure elucidation in natural products research and drug discovery [63] [64].
Effective CASE application requires an understanding of the quantitative landscape of natural product space and the performance characteristics of constituent fragment libraries. The following tables summarize key chemoinformatic data essential for library design and evaluation.
Table 1: Structural and Diversity Metrics of Representative Natural Product Fragment Libraries
| Library / Source | Avg. Molecular Weight (Da) | Avg. Heavy Atoms | Avg. Fsp³ | Key Structural Features | Pairwise Similarity (Tanimoto, Morgan2) | Reference |
|---|---|---|---|---|---|---|
| Colombian NP (NPDBEjeCol) | ~234 | ~17 | High | Rich in oxygen, low N, tetrahydropyran rings, phenolic moieties | Highest uniqueness; minimal fragment overlap with other sets [65] | [65] |
| COCONUT (Full Database) | Not specified | Not specified | High | Maximum chemical diversity from >400,000 NPs | Low median similarity, indicating high diversity [66] | [66] |
| Pseudo-NP (Designed) | 150-300 | Variable | Very High (Fsp³ >0.45 target) | 3D-shaped, chiral centers, combined biosynthetic scaffolds | Occupies novel, inaccessible regions of NP chemical space [63] | [63] |
| FDA-Approved Drugs | 358-386 | 26-28 | Moderate | Higher nitrogen & sulfur content, more aromatic rings | Distinct from NP-derived libraries in chemical space [65] | [65] |
| Rule-of-Three Compliant | ≤300 | ≤22 | Variable | clogP ≤3, HBD ≤3, HBA ≤3, PSA ≤60 Ų | Optimized for solubility and ligand efficiency in biophysical assays [67] | [67] |
Table 2: Input Data Quality Tolerances for CASE System Performance
| Parameter | Optimal Specification | Acceptable Range | Impact on CASE Output | Corrective Action |
|---|---|---|---|---|
| ¹H NMR Resolution | < 1 Hz | 1-2 Hz | Broad peaks lead to missed correlations; inaccurate coupling constants. | Optimize shimming, sample prep, use higher field instrument. |
| ¹³C NMR Signal-to-Noise (S/N) | > 100:1 | > 50:1 | Low S/N causes erroneous peak picking and missing quaternary carbons. | Increase scan count, concentrate sample, use cryoprobe. |
| HSQC/HMBC Peak Picking Accuracy | > 98% correct correlations | > 90% | Incorrect peaks generate invalid structural constraints, causing combinatorial explosion or wrong solution [34]. | Manual verification, use of adaptive thresholding algorithms. |
| Molecular Formula Accuracy (HR-MS) | < 3 ppm error | < 5 ppm error | Incorrect formula leads to generation of impossible structures. | Calibrate instrument with standard; use internal reference. |
| Number of HMBC Correlations per Carbon | ≥ 2-3 | ≥ 1 | Insufficient long-range constraints fail to define molecular connectivity [26]. | Acquire with longer mixing time (e.g., 8-10 Hz JCH). |
Objective: To extract accurate and complete atom-atom correlation lists from 2D NMR spectra (HSQC, HMBC, COSY) for input into a CASE system [34] [26].
Materials:
Procedure:
Initial Processing:
Automated Peak Picking with Adaptive Parameters:
Manual Curation and Validation:
Data Export:
Objective: To create a targeted fragment library from natural products for use in CASE to seed structure generation or validate candidate structures [63] [65] [66].
Materials:
Procedure:
Database Curation:
In Silico Fragmentation:
Library Annotation & Formatting:
Integration with CASE Workflow:
Diagram 1: CASE Workflow with Critical Input Optimization Stages
Diagram 2: Natural Product Fragment Library Generation and Application Pipeline
Diagram 3: Data Quality and Consistency Validation Logic Pathway
Table 3: Key Reagents, Software, and Databases for CASE-Driven Natural Products Research
| Item / Resource | Category | Primary Function in CASE Context | Key Features / Notes | Reference / Source |
|---|---|---|---|---|
| ACD/Structure Elucidator Suite | CASE Software | Core platform for de novo structure generation from spectral data. | Generates Molecular Connectivity Diagrams (MCD), ranks candidates via DP4/ deviation, integrates fragment libraries, processes vendor-agnostic data [34]. | Commercial Software [34] |
| CISOC-SES | CASE Expert System | Automated structure elucidation and resonance assignment. | Demonstrated application to complex NPs (e.g., betulinic acid); uses spectral data independent of background info [64]. | Academic/Research Software [64] |
| RDKit with MolVS | Cheminformatics Toolkit | Data curation, standardization, and fragmentation (RECAP). | Open-source. Essential for curating NP databases and generating standardized fragment libraries [66]. | Open-Source Library |
| COCONUT (COlleCtion of Open NatUral producTs) | NP Database | Source of >400,000 compounds for fragment library generation. | Largest open-access NP database; provides immense scaffold diversity for fragment mining [66]. | Public Database [66] |
| Dictionary of Natural Products (DNP) | NP Database | Source of curated, characterized natural products. | Contains fragment-sized NPs; used for analysis of 3D shape and sp3 richness [63]. | Commercial Database |
| SPiDER Software | Target Prediction | Predicts biological targets for fragment-sized natural products. | Guides hypothesis generation by linking NP fragments to potential protein targets (e.g., sparteine to opioid receptor) [63]. | Commercial/Research Software [63] |
| Deuterated NMR Solvents (e.g., DMSO-d6, CD3OD) | Research Reagent | Provide stable, non-interfering medium for NMR analysis. | Essential for obtaining high-resolution, reproducible 2D NMR spectra. Low water content is critical. | Commercial Supplier |
| RECAP Algorithm | Computational Method | Retrosynthetically cleaves molecules into sensible fragments. | Creates "privileged" fragments with synthetic handles; standard for NP fragment library creation [66] [67]. | Algorithm [66] |
| TMAP Visualization | Chemoinformatics Tool | Visualizes high-dimensional chemical space of large fragment libraries. | Enables intuitive analysis of library diversity and overlap between NP and drug-like spaces [66]. | Open-Source Algorithm [66] |
The structure elucidation of complex natural products and ambiguous isomers remains a significant challenge in drug discovery. This article details application protocols for integrating Nuclear Magnetic Resonance (NMR) and Infrared (IR) spectroscopic data within a Computer-Assisted Structure Elucidation (CASE) framework. The described methodologies leverage multivariate data analysis and emerging machine learning techniques trained on multimodal datasets to resolve structural ambiguities that single spectroscopic techniques cannot. This integrated approach provides a more robust, efficient, and less error-prone pathway for determining novel molecular structures in natural products research [37] [3].
The history of structure elucidation is marked by technological revolutions, from crystallography to NMR spectroscopy [68]. Despite advancements, a "disturbing number" of incorrect natural product structures are still reported, often due to interpretive errors from incomplete or ambiguous data [37]. Computer-Assisted Structure Elucidation (CASE) systems were developed to address this by generating all possible structures consistent with spectroscopic data and ranking them by probability [37] [3]. While powerful, traditional CASE programs primarily rely on 2D NMR data (COSY, HMBC) and can struggle with isomers that produce near-identical NMR correlations or contain uncommon structural motifs [37].
Multimodal integration, particularly of NMR and IR data, offers a compelling solution. NMR excels at mapping carbon-hydrogen frameworks and connectivity, while IR spectroscopy provides sensitive, complementary information on functional groups and bond vibrations. Combining these orthogonal data streams provides a more complete structural fingerprint. As experts note, just as analysts use multiple techniques simultaneously, machine learning models trained on combined FT-IR and NMR data outperform those using a single spectral type for functional group identification [69]. This synergy is now being propelled by the availability of large-scale synthetic spectral datasets and advanced multivariate analysis software, moving multimodal CASE from a specialized concept to a practical, high-throughput protocol [70] [71].
This protocol standardizes the acquisition and preparation of NMR and IR data for integrated CASE analysis, ensuring consistency and machine-readability.
This protocol outlines steps for generating high-quality synthetic spectral data to train or benchmark machine learning models for structure elucidation, based on methods used to create large public datasets [70].
This protocol describes using a pre-trained multimodal artificial neural network (ANN) to analyze experimental spectra of an unknown compound, providing functional group predictions and isomer discrimination.
[IR_Absorbance_1, ..., IR_Absorbance_N, ¹H_Bin_1, ..., ¹H_Bin_12, ¹³C_Bin_1, ..., ¹³C_Bin_44].
Diagram 1: Workflow for Multimodal Spectroscopy-Enhanced CASE
The quantitative advantage of integrating multimodal spectroscopic data is evident in the performance of machine learning models.
Table 1: Performance Comparison of Spectroscopy Models for Functional Group Identification [69]
| Model Input Data | Macro-Average F1 Score | Key Advantage | Primary Limitation |
|---|---|---|---|
| FT-IR Only | 0.88 | Excellent for specific bonds (C=O, O-H) | Overlap in fingerprint region; silent modes |
| ¹³C NMR Only | 0.85 | Direct carbon environment information | Low sensitivity; no proton info |
| ¹H NMR Only | 0.79 | High sensitivity; connectivity via J-coupling | Complex multiplet patterns; signal overlap |
| Multimodal (IR + ¹H + ¹³C NMR) | 0.93 | Complementary data resolves ambiguities; robust to weak signals | Requires all three datasets; more complex preprocessing |
Table 2: Key Specifications of the IR-NMR Multimodal Computational Dataset [70]
| Feature | Specification |
|---|---|
| Total Molecules | 177,461 (IR), 1,255 (NMR subset) |
| Molecular Source | USPTO Patent Database |
| Heavy Atom Range | 5 to 35 |
| IR Spectral Type | Anharmonic, from MD dipole autocorrelation |
| NMR Data | ¹H & ¹³C chemical shifts from DFT calculations |
| Computational Method | Hybrid MD-DFT with ML acceleration (DeepPot-SE) |
| Primary Use Case | Training/benchmarking ML models for joint spectral interpretation |
| Data Accessibility | Open access via Zenodo |
Table 3: Essential Tools for Multimodal Spectroscopic Analysis
| Category | Item / Software | Primary Function in Protocol |
|---|---|---|
| Computational Chemistry & MD | GAFF2 Force Field [70] | Provides parameters for classical molecular dynamics simulations of organic molecules. |
| LAMMPS [70] | High-performance molecular dynamics simulator used to generate conformational trajectories. | |
| CPMD / Gaussian / ORCA [70] | Software for Density Functional Theory (DFT) calculations to predict NMR chemical shifts and accurate dipole moments for IR. | |
| Cheminformatics & ML | RDKit [70] | Open-source toolkit for cheminformatics; used to process SMILES, generate 3D coordinates, and handle molecule I/O. |
| DeePMD-kit [70] | Implements the Deep Potential framework for training machine learning potentials to accelerate spectral calculations. | |
| Python (SciKit-Learn, PyTorch/TensorFlow) | Ecosystem for building, training, and deploying the multimodal artificial neural network (ANN) models. | |
| Data Analysis & CASE | SIMCA [71] | Multivariate Data Analysis (MVDA) software for advanced spectral preprocessing, PCA, PLS, and classification. |
| ACD/Structure Elucidator [3] | A leading CASE expert system that uses spectroscopic data to generate and rank plausible chemical structures. | |
| Reference Databases | USPTO-Spectra Dataset [70] | A large-scale synthetic dataset of anharmonic IR and NMR spectra for training multimodal ML models. |
| NIST Chemistry WebBook [69] | Public repository of experimental IR spectra used for model training and validation. | |
| SDBS (Spectral Database) [69] | Public repository of experimental NMR spectra used for model training and validation. |
Diagram 2: Computational Pipeline for Synthetic Spectral Data Generation
The integration of multimodal spectroscopic data, particularly NMR and IR, within a CASE framework represents a powerful evolution in structure elucidation. Protocols that leverage multivariate analysis of fused spectral data and machine learning models trained on large-scale computational datasets provide a systematic approach to resolving ambiguous isomers. This not only increases accuracy but also accelerates the discovery pipeline for natural products and pharmaceuticals.
The future of this field is closely tied to advances in artificial intelligence and data availability. The development of large, high-quality multimodal spectral datasets will enable the training of more sophisticated "foundation models" for spectroscopy [70]. Furthermore, the direct integration of these AI tools into commercial CASE software will make multimodal analysis a routine, accessible step for researchers. As these tools evolve, the vision of a fully automated, highly reliable analytical workflow for determining complex natural product structures moves closer to reality, promising to unlock novel chemical space for drug discovery [37] [3].
The structure elucidation of natural products represents a persistent bottleneck in drug discovery. These molecules, often large, structurally dense, and rich in stereogenic centers, defy analysis by conventional methods. Computer-Assisted Structure Elucidation (CASE) systems have emerged as transformative tools, shifting the paradigm from manual, expertise-dependent interpretation to automated, data-driven deduction [58]. The core challenge in applying CASE to complex natural products lies in the strategic selection of algorithms and the precise tuning of their parameters to navigate the vast, combinatorial chemical space efficiently and accurately.
Traditional exhaustive structure generation approaches become computationally intractable for molecules with more than 30 heavy atoms or intricate polycyclic systems. Consequently, modern protocols increasingly rely on hybrid strategies that integrate physics-based spectral matching, fragment-based assembly, and machine learning optimization [73]. The performance of these algorithms is highly sensitive to input parameters, where suboptimal choices can lead to failed elucidations, erroneous structures, or prohibitive computational cost. This document provides detailed application notes and protocols for algorithm selection and parameter tuning, framed within a practical workflow for the CASE-driven analysis of large or structurally dense natural products.
Selecting the appropriate algorithm is the first critical step. The choice depends on the primary data available, the suspected molecular complexity, and the computational resources at hand.
For problems where Nuclear Magnetic Resonance (NMR) data is the primary source, algorithms that bypass exhaustive generation are essential. The NMR-Solver framework exemplifies this approach, integrating large-scale spectral database matching with physics-guided, fragment-based optimization [73]. It uses a two-stage process: first, retrieving candidate molecular fragments from a spectral database using deep learning-based similarity search; second, assembling these fragments into complete candidate structures through a Markov Chain Monte Carlo (MCMC) process guided by a scoring function that combines spectral match quality and molecular stability.
Performance Data: Benchmarking on experimental datasets shows NMR-Solver can identify correct structures for molecules with 20-35 heavy atoms, where traditional CASE might generate millions of candidates. Its fragment-based approach reduces the candidate pool by several orders of magnitude prior to final ranking [73].
When the problem involves searching ultra-large, make-on-demand chemical libraries (e.g., billions of compounds) for hits against a biological target, exhaustive docking is impossible. Evolutionary algorithms (EAs) like REvoLd are designed for this task [74]. They treat molecules as individuals in a population, with fitness defined by a scoring function (e.g., docking score). Through iterative cycles of selection, crossover (fragment exchange), and mutation (fragment replacement), the population evolves toward higher fitness.
Key Hyperparameter Insights from REvoLd: [74]
Table 1: Comparative Performance of Algorithmic Approaches for Large Molecules
| Algorithm Type | Primary Data Input | Best For | Key Strength | Computational Scale | Reported Enrichment/Accuracy |
|---|---|---|---|---|---|
| Fragment-Based (NMR-Solver) [73] | ¹H/¹³C NMR Spectra | Structure elucidation of novel, medium-large organics | Integrates physical principles & database learning; highly interpretable | Minutes to hours on GPU | >80% top-1 accuracy on experimental benchmarks |
| Evolutionary (REvoLd) [74] | 3D Protein Target, Fragment Libraries | Screening ultra-large combinatorial libraries | Efficient exploration of billion+ molecule spaces with flexible docking | Thousands of docking calc. vs. billions | 869x to 1622x hit rate enrichment over random |
| In-Context LLM (LICO) [75] | Molecular String (SMILES), Property Labels | Black-box molecular optimization tasks | Generalizes to new objectives with minimal examples | Fast inference after training | State-of-the-art on PMO-1K low-budget benchmark |
| Bayesian-Optimized Clustering (DBOpt) [76] | Spatial Coordinates (e.g., SMLM data) | Analyzing nanoscale molecular organization in imaging | Unbiased, automated parameter selection for density-based clustering | Efficient validation for large point clouds | Accurately recovers feature sizes in 2D/3D experimental data |
For steps requiring high-accuracy quantum mechanical calculations, such as final structure ranking or geometry optimization, Neural Network Potentials (NNPs) trained on massive datasets like OMol25 offer DFT-level accuracy at a fraction of the computational cost [77]. These models, such as the eSEN and UMA architectures, are essential for making quantum chemical validation feasible for large molecules.
For generative tasks or property prediction, Large Language Model (LLM)-based approaches like LICO demonstrate strong in-context learning [75]. LICO can be adapted to optimize diverse molecular properties by learning from a small set of example input-output pairs provided in its prompt, making it flexible for scenarios with limited labeled data.
Algorithm performance is critically dependent on parameters. Manual tuning is inefficient and non-reproducible. The following automated methodologies are recommended.
In analyses like single-molecule localization microscopy (SMLM), defining clusters of molecular localizations is key. Density-based algorithms like DBSCAN require parameters (eps, min_samples) that are non-intuitive to set. The DBOpt protocol uses an efficient Density-based Cluster Validation (DBCV) score as an internal validation metric and couples it with Bayesian optimization to find the parameter set that maximizes this score [76].
Protocol: DBOpt for SMLM Data Clustering [76]
eps (e.g., 1-100 nm) and min_samples (e.g., 5-50).Tuning EAs requires balancing exploration and exploitation. The REvoLd study established a protocol based on iterative testing on a pre-scored subset of the chemical space [74].
Protocol: Tuning an EA for Library Screening
Table 2: Parameter Tuning Methods and Key Metrics
| Tuning Method | Best Applied To | Core Principle | Evaluation Metric | Advantage |
|---|---|---|---|---|
| Bayesian Optimization with DBCV [76] | Density-based clustering parameters (e.g., DBSCAN) | Maximize an internal validity index (DBCV) via surrogate model | DBCV Score (-1 to 1) | Fully automated; unbiased; requires no ground truth |
| Iterative Benchmarking on Subset [74] | Evolutionary algorithm operators & rates | Empirical performance testing on a manageable representative sample | Hit Rate, Scaffold Diversity | Pragmatic; directly optimizes for application-specific outcomes |
| Grid/ Random Search | Generic algorithm hyperparameters | Systematic or random sampling of parameter space | Any relevant performance score (e.g., accuracy, loss) | Simple to implement; embarrassingly parallel |
| In-Context Learning [75] | Adapting LLMs to new tasks | Providing task examples within the model's prompt | Task-specific performance (e.g., property value) | Requires no retraining; highly flexible for new problems |
Diagram 1: DBOpt Workflow for Automated Parameter Tuning (Max Width: 760px)
This section outlines a step-by-step protocol for applying the discussed algorithms to revise or elucidate the structure of a complex natural product.
This protocol, based on the analysis of 12 real revision cases [58], aims to verify or correct a proposed structure before costly total synthesis.
Materials & Input Data: Published (^1)H and (^{13})C NMR chemical shifts, HSQC, HMBC, and COSY correlations (even if incomplete or containing errors); Molecular formula from HRMS. Workflow:
Diagram 2: CASE/DFT Structure Revision Workflow (Max Width: 760px)
For a completely unknown, complex molecule, an integrated protocol combining several algorithms is necessary.
Workflow:
Table 3: Essential Computational Tools for CASE of Complex Molecules
| Tool / Resource | Type | Primary Function in CASE | Key Feature for Large Molecules | Reference/Example |
|---|---|---|---|---|
| ACD/Structure Elucidator | Commercial Software Suite | Core CASE platform for structure generation & ranking | Fuzzy Structure Generation handles inconsistent data; handles large structure sets. | [58] |
| NMR-Solver | AI/Physics Framework | Automated structure elucidation from NMR spectra | Fragment-based assembly avoids combinatorial explosion. | [73] |
| Gaussian, ORCA, PSI4 | Quantum Chemistry Packages | DFT NMR/ECD calculations for final validation | Can be coupled with NNPs for faster geometry steps. | Standard Tools |
| Meta OMol25 NNPs (eSEN, UMA) | Pre-trained Neural Potentials | High-accuracy energy/force calculations | Near-DFT accuracy for biomolecules & metal complexes at low cost. | [77] |
| Rosetta (REvoLd) | Molecular Modeling Suite | Evolutionary screening of ultra-large libraries | Efficiently searches billion-molecule spaces with flexible docking. | [74] |
| DBOpt Implementation | Clustering Optimization Script | Automated parameter tuning for DBSCAN/HDBSCAN | Enables robust analysis of SMLM data from complex cellular structures. | [76] |
| HMDB, NP-MRD, LOTUS | Public Spectral & Natural Product DBs | Reference data for spectral matching & dereplication | Critical for fragment retrieval and prior knowledge integration. | [60] |
The future of CASE for natural products lies in moving beyond isolated algorithms toward integrated, reasoning systems. The next paradigm involves constructing a Natural Product Science Knowledge Graph [60]. This graph would connect nodes representing chemical structures, spectroscopic data, genomic biosynthetic gene clusters, and biological activity through defined relationships. Algorithm selection and parameter tuning would then be guided by this global knowledge structure. For instance, an AI model could recommend an NMR-Solver-first protocol for a molecule whose partial structure appears linked to a specific biosynthetic pathway in the graph, or suggest starting parameters for an EA based on the historical performance of similar scaffolds. This shift from manual protocol design to AI-assisted, knowledge-informed workflow generation will be essential for tackling the growing complexity of natural product discovery and fully realizing the potential of computer-assisted structure elucidation.
The structural elucidation of novel natural products represents a fundamental challenge in drug discovery and chemical research. Despite advanced spectroscopic techniques, misassignments—particularly of complex stereochemistry—persist as a significant problem, undermining downstream research and development efforts [78]. Within this context, Computer-Assisted Structure Elucidation (CASE) systems have emerged as indispensable tools, leveraging algorithms to generate all possible structural candidates consistent with experimental spectroscopic data [4] [26].
However, the output of a CASE system is typically a ranked list of plausible isomers. The final, critical step is validation: determining which candidate structure is correct with the highest possible confidence. Traditional metrics like the correlation coefficient (R²) or Mean Absolute Error (MAE) between calculated and experimental Nuclear Magnetic Resonance (NMR) chemical shifts have limitations, as they do not provide a statistical measure of probability and can be skewed by systematic errors [78].
This is where advanced validation metrics, specifically DP4/DP4* probabilities and Chemical Shift Deviation (CSD) scores, become paramount. These metrics transform qualitative assessment into a quantitative, statistically robust decision-making process. DP4* (an enhanced version of the original DP4) employs Bayesian analysis to compute the probability that each candidate structure is the correct one, based on the distribution of errors between density functional theory (DFT)-calculated and experimental NMR shifts [78]. When integrated into the CASE workflow, these metrics provide a powerful, objective filter, drastically reducing the risk of publication and propagation of incorrect structures.
The DP4 method, introduced by Goodman and later refined to DP4+ (or DP4), is a Bayesian probability tool designed to assign the most likely structure among a set of candidates [78]. Its core innovation is treating the discrepancies between DFT-calculated and experimental chemical shifts as arising from a known probability distribution (a *t-distribution).
While DP4 provides a probabilistic ranking, CSD and RMSD scores offer complementary, intuitive measures of the absolute agreement between calculation and experiment.
Table 1: Performance Summary of DP4/DP4* and Traditional Metrics
| Metric | Statistical Basis | Key Output | Typical Threshold for Confidence | Primary Advantage | Primary Limitation |
|---|---|---|---|---|---|
| DP4* | Bayesian probability (t-distribution) | Probability (0-100%) that a candidate is correct. | >95% considered highly confident; >99% is definitive [78]. | Provides objective statistical probability; excellent for stereochemistry. | Requires accurate DFT calculations; performance depends on correct parameter set. |
| MAE | Descriptive statistics | Average error in ppm. | Varies by nucleus: ~0.1-0.3 ppm for ¹H; ~1-3 ppm for ¹³C. | Simple, intuitive measure of average agreement. | Non-probabilistic; can be deceptively low for wrong structures with scaled data. |
| RMSD | Descriptive statistics | Root-mean-square error in ppm. | Slightly higher than MAE; similar variability. | Penalizes large outliers more than MAE. | Non-probabilistic; cannot statistically distinguish between candidates. |
| CMAE | Descriptive statistics (scaled) | Scaled average error in ppm. | Similar to MAE but more consistent across calculation levels. | Removes systematic linear bias from calculations. | Still a non-probabilistic measure. |
The following protocol outlines the steps for employing these validation metrics, from CASE system output to final structural assignment.
Phase 1: Candidate Generation via CASE
Phase 2: In-depth Validation with DFT and DP4*
Diagram 1: Integrated CASE and DP4 Validation Workflow. This chart outlines the process from raw data to a validated structure, highlighting the critical, iterative role of DP4* probability analysis [78] [4] [34].
Diagram 2: DP4* Probability Calculation Logic. This diagram illustrates the core algorithmic steps within the DP4* calculation, showing how data categorization and Bayesian inference produce the final probability score [78].
Successfully implementing this protocol requires access to specific computational tools and databases.
Table 2: Research Reagent Solutions for CASE & DP4 Validation
| Tool/Resource Category | Specific Example(s) | Function & Role in Validation |
|---|---|---|
| Commercial CASE Suite | ACD/Structure Elucidator [34] | Industry-standard platform for automated structure generation from NMR/MS data. Provides initial candidate list and can integrate DP4 scoring. |
| Open-Source CASE System | Sherlock [30] | Free, modular system for peak picking, constraint management, and structure generation. Enables transparent workflow. |
| Quantum Chemistry Software | Gaussian, ORCA, Spartan | Performs the essential DFT calculations for geometry optimization and NMR chemical shift prediction at high levels of theory. |
| DP4 Calculation Interface | DP4+ Excel Spreadsheet [78] | User-friendly tool to input calculated and experimental shifts and automatically compute DP4* probabilities. |
| Conformational Search Software | CONFLEX, MacroModel, RDKit | Systematically explores the conformational landscape of flexible molecules to ensure accurate Boltzmann-averaged NMR predictions. |
| Chemical Shift Database | NMRShiftDB, SDBS | Public repositories of experimental NMR data used for dereplication and as benchmarks for calculated shifts. |
Within the modern framework of computer-assisted structure elucidation for natural products, validation is not a final step but an integral, guiding principle. The synergistic use of DP4/DP4* probability analysis and Chemical Shift Deviation scores provides a rigorous, quantitative foundation for moving from a list of computational possibilities to a single, high-confidence structural assignment. As documented in numerous case studies, including complex peptides like cyclocinamide A [79], this methodology significantly reduces the rate of structural misassignment. Its integration into commercial and open-source CASE platforms [34] [30] marks a critical advancement towards more reliable, efficient, and data-driven natural product discovery, directly supporting the development of new therapeutic agents.
The structural elucidation of novel natural products represents a central, yet often bottleneck, challenge in drug discovery and chemical ecology. Traditional manual interpretation of Nuclear Magnetic Resonance (NMR) spectra is a time-intensive process heavily reliant on expert knowledge. Computer-Assisted Structure Elucidation (CASE) systems have emerged as transformative tools, leveraging algorithms to propose and rank candidate structures from spectroscopic data, thereby enhancing the speed, objectivity, and reliability of the process [3]. Within the context of a broader thesis on CASE for natural products, this analysis provides detailed application notes and protocols for leading commercial and open-source platforms. The evolution of CASE, from early fragment-based systems to modern expert systems capable of handling complex natural products with 40 or more heavy atoms, underscores its growing indispensability in the researcher's toolkit [80] [3].
The landscape of CASE software includes mature commercial suites and emerging open-source alternatives, each with distinct approaches to the elucidation workflow. The following table summarizes the core characteristics, strengths, and primary use cases for four key platforms.
Table: Comparative Analysis of Leading CASE Platforms
| Platform | Provider / Type | Core Methodology | Key Strength | Typical Use Case |
|---|---|---|---|---|
| ACD/Structure Elucidator | ACD/Labs (Commercial) | Expert system with automated Molecular Connectivity Diagram (MCD) generation and structure ranking [34]. | Most peer-reviewed; high performance for complex, novel natural products; integrated fragment and database search [34] [3]. | De novo elucidation of complex, unprecedented structures in natural product research. |
| Mnova Structure Elucidation | Mestrelab (Commercial) | Integrated workflow within Mnova NMR suite, utilizing the COCON structure generator [80] [35]. | User-friendly interface; seamless with NMR processing; robust for routine small molecule elucidation [35]. | Streamlined structure determination in organic chemistry and drug discovery workflows. |
| Bruker CMC-se | Bruker (Commercial) | Automated analysis integrated with AVANCE NMR spectrometers; focuses on correlation table generation [42]. | Tight instrument integration; robust handling of data imperfections; strong verification tools [42]. | Structure verification and elucidation in labs using Bruker NMR systems, including academic teaching. |
| Sherlock | Open-Source | Modular system combining NMRium (peak picking), pyLSD (structure generation), and ranking algorithms [80]. | Full user control and transparency; customizable workflow; facilitates methodology research and education [80]. | Academic research, method development, and educational purposes where cost and openness are priorities. |
3.1 Generic CASE Workflow for Natural Products A standard CASE protocol begins with the acquisition of a purified compound. The minimum recommended dataset includes 1D ¹H and ¹³C NMR, and 2D spectra (HSQC, HMBC, COSY) to define through-bond connectivities [34]. The molecular formula, typically determined by high-resolution mass spectrometry (HR-MS), is a critical input. The subsequent computational workflow is illustrated below.
Diagram Title: Standard Computer-Assisted Structure Elucidation (CASE) Workflow
3.2 Platform-Specific Protocols
Table: Key Research Reagent Solutions for CASE-Supported Natural Product Elucidation
| Item | Function & Role in CASE Workflow |
|---|---|
| Deuterated NMR Solvents (e.g., CDCl₃, DMSO-d₆, CD₃OD) | Provides a stable, non-interfering magnetic environment for acquiring high-resolution, reproducible NMR spectra, which is the foundational data for all CASE systems. |
| MS-Grade Solvents & Ionization Agents (e.g., Formic acid, TFA, Na/Ag salts for cationization) | Essential for obtaining high-resolution mass spectrometry (HR-MS) data to determine the exact molecular formula, a critical constraint for structure generation [34]. |
| NMR Reference Standards (e.g., Tetramethylsilane (TMS), solvent residual peaks) | Provides a universal chemical shift (δ) reference for accurate peak picking and calibration, ensuring data consistency across platforms and laboratories. |
| Chromatography Media (e.g., Sephadex LH-20, C18 silica) | For the purification of natural product extracts to obtain the single compound required for classical CASE analysis, moving beyond direct mixture analysis [39]. |
| Structure Verification Compounds (e.g., Mosher's esters, chiral shift reagents) | Used to experimentally determine absolute configuration, providing critical validation for stereochemical assignments proposed by CASE systems using NOE/ROE data. |
Despite their power, current CASE systems face inherent limitations. A primary challenge is their dependence on correct and unambiguous peak picking from 2D NMR spectra; errors here directly propagate to invalid structural constraints [34]. Furthermore, CASE algorithms can struggle with molecules exhibiting high symmetry or regions of low proton density, where insufficient HMBC correlations create ambiguous connectivity networks [81]. The elucidation of stereochemistry remains less automated than planar structure determination, often requiring additional experimental data.
Future development is focused on integrating artificial intelligence and machine learning to address these gaps. Emerging tools like DeepSAT use convolutional neural networks (CNNs) to directly predict structural features or identify known analogues from HSQC spectra alone, potentially streamlining the initial dereplication and fragment identification steps [82]. Another trend is the move towards the analysis of complex mixtures without full purification, using techniques like DOSY, STOCSY, and machine learning models to deconvolute spectra and identify bioactive components [39] [83]. The continued expansion of open-source platforms and shared data formats (e.g., NMReData) promises to enhance reproducibility, collaboration, and the development of next-generation, hybrid AI-CASE systems [80] [42].
The discovery and development of therapeutics from Natural Products (NPs) represent a historically rich yet notoriously challenging frontier in drug discovery [84]. NPs possess unique chemical diversity and potent bioactivity, but their structural complexity, heterogeneity, and the labor-intensive process of isolation and characterization create significant bottlenecks [85] [84]. Computer-Assisted Structure Elucidation (CASE) has emerged as a critical discipline to address these challenges, systematically applying computational methods to determine the chemical structures of unknown compounds. Traditionally, CASE has relied on spectroscopic data interpretation and empirical rules. Today, the integration of Artificial Intelligence (AI) and Machine Learning (ML) is fundamentally transforming CASE workflows, dramatically enhancing both the accuracy and speed of predictions [85] [86].
This transformation is driven by AI's capacity to discern complex, non-linear patterns within multidimensional data—such as NMR spectra, mass spectrometry fragmentation patterns, and genomic sequences—that elude conventional analysis [84] [87]. Within the context of a broader thesis on CASE for natural products research, this article details the application of AI/ML protocols, focusing on their role in accelerating the journey from raw spectroscopic data to a confidently elucidated, biologically relevant structure. The fusion of AI with advanced computational chemistry and experimental validation is paving the way for a new era of efficient, data-driven natural product discovery [88] [86].
The enhancement of CASE by AI is underpinned by several advanced computational methodologies. These approaches move beyond simple pattern matching to enable predictive modeling, generative design, and integrative analysis of multimodal data.
Graph Neural Networks (GNNs) and Molecular Representation: GNNs have become a cornerstone for representing chemical structures within ML models. In a CASE context, a molecule is treated as a graph where atoms are nodes and bonds are edges. GNNs can learn features directly from this graph structure or from spectroscopic data mapped onto it. This is particularly powerful for interpreting 2D-NMR datasets (like HSQC, HMBC), where proton-carbon correlation data can be formulated as connectivity graphs. Models such as Algebraic Graph Learning (AGL) scoring functions use weighted colored subgraphs from 3D protein-ligand complexes to predict binding affinities, a principle adaptable to scoring plausible structural interpretations against spectral data [89].
Generative AI for Structure Proposal and Expansion: Generative models, including Generative Adversarial Networks (GANs) and Transformer-based architectures, are used to propose novel chemical structures that conform to both spectral constraints and desirable chemical properties. For instance, the NPDL-GEN model combines a GPT-like generator with an Augmented Hill-Climb strategy to produce synthetically accessible "pseudo-natural products" with optimized drug-likeness [90]. In a CASE pipeline, such models can generate a diverse set of candidate structures that explain observed spectroscopic features, expanding the solution space beyond known databases.
Knowledge Graphs for Multimodal Data Integration: A significant challenge in NP research is the fragmentation of data across modalities (genomics, metabolomics, spectroscopy, bioactivity) [87]. Knowledge Graphs (KGs) provide a powerful framework to unify these disparate data types. Entities (e.g., a compound, a biosynthetic gene cluster, a spectral peak, a biological target) are represented as nodes, and their relationships (e.g., "produces," "correlates with," "inhibits") as edges. AI models can then traverse this graph for reasoning and prediction. For example, a KG can link a mass spectrometry feature to a predicted biosynthetic pathway from a genome, suggesting a potential structural class before isolation is complete. Frameworks like the Experimental Natural Products Knowledge Graph (ENPKG) demonstrate how this integration enriches data interpretation and discovery [87].
Hybrid Physics-Based and ML Models: Pure data-driven ML models can sometimes lack physical realism or perform poorly outside their training domain. Hybrid models that integrate physics-based simulations with ML are gaining traction. In kinetics and free energy prediction, hybrid Quantum Mechanical/Machine Learning (QM/ML) models achieve high accuracy at a fraction of the computational cost of pure ab initio methods [91]. For CASE, this approach can be used to predict NMR chemical shifts or coupling constants with quantum-mechanical accuracy but at high speed, providing a critical benchmark for proposed structures.
Table 1: Core AI/ML Methodologies and Their Applications in CASE Workflows
| Methodology | Key Features | Primary Application in CASE | Impact on Speed/Accuracy |
|---|---|---|---|
| Graph Neural Networks (GNNs) | Learns directly from molecular graph structure; handles relational data. | Interpreting 2D-NMR correlation data; scoring structure-spectra matches [89]. | High Accuracy: Improves interpretation of complex spin systems. Speed: Automates connectivity mapping. |
| Generative Models (GANs, Transformers) | Generates novel molecular structures from learned distributions. | Proposing candidate structures consistent with spectral data; designing pseudo-natural products [90]. | High Speed: Rapidly enumerates plausible candidates. Expanded Scope: Explores novel chemical space. |
| Knowledge Graphs (KGs) | Integrates heterogeneous, multimodal data into a relational network. | Unifying genomic, spectroscopic, and bioactivity data for holistic candidate prioritization [87]. | High Accuracy: Contextualizes evidence from multiple sources. Speed: Facilitates rapid data retrieval and hypothesis generation. |
| Hybrid QM/ML Models | Combines physics-based simulation with data-driven ML efficiency. | Predicting accurate NMR parameters (δ, J) and stability/conformation of candidates [91]. | High Accuracy: Near-QM accuracy for properties. Speed: Orders of magnitude faster than full QM calculation. |
Objective: To automatically interpret 1D/2D-NMR and MS data and assemble a ranked list of plausible molecular structures. Background: Traditional structure elucidation relies on expert manual interpretation of spectra. This protocol uses a GNN-based pipeline to automate the process, significantly reducing time and subjectivity [89].
Materials & Input Data:
Procedure:
Objective: To generate novel, synthetically accessible compound libraries inspired by natural product scaffolds for virtual screening. Background: This protocol leverages the NPDL-GEN framework to overcome the limitations of natural product availability and complexity by generating optimized "pseudo-NPs" [90].
Materials & Input Data:
Procedure:
Objective: To integrate disparate data sources into a unified Knowledge Graph to provide biological and chemical context for a structure elucidation project. Background: This protocol outlines steps to construct a domain-specific KG, enabling AI to reason across genomics, metabolomics, and literature, thereby informing and validating structural hypotheses [87].
Materials & Input Data:
Procedure:
Compound, Spectrum, BGC, Organism, BiologicalTarget, Assay. Key relationships include Organism_PRODUCES_Compound, Compound_HAS_MS2_Spectrum, BGC_ENCODES_BiosynthesisOf, Compound_INHIBITS_Target.Compound node for artemisinin in the database.Unknown_1) is under investigation, its observed properties (molecular ion, fragment ions, source organism) are added as nodes. The KG is then queried via graph algorithms:
Unknown_1 can be validated by checking the KG for existing compounds with similar structures and their reported biological activities. If the source organism's extract shows a specific bioactivity, and the proposed structure is linked (via the KG) to a known target relevant to that activity, confidence in the elucidation increases.
AI-Driven CASE Workflow Integrating ML & Knowledge
Knowledge Graph Reasoning for Structure Elucidation
Table 2: Key Research Reagent Solutions for AI-Enhanced CASE Protocols
| Category | Item / Solution | Function in CASE Workflow | Example / Note |
|---|---|---|---|
| Computational Software | GNN-based Scoring & Docking Software | Scores protein-ligand binding affinity or structure-spectra match; critical for ranking candidates [88] [89]. | Gnina (CNN-based scoring) [89], AGL-EAT-Score [89]. |
| Generative Chemistry Platforms | Generates novel, valid molecular structures conditioned on desired properties or spectral constraints [90]. | NPDL-GEN model [90], Molecular Transformer models. | |
| Retrosynthesis & Reaction Prediction AI | Predicts feasible synthetic routes for proposed or generated structures, assessing synthetic accessibility [91]. | Tools leveraging Monte Carlo Tree Search (MCTS) & neural networks [91]. | |
| Knowledge Graph Database System | Stores and queries interconnected multimodal data for context-aware reasoning [87]. | Neo4j, Amazon Neptune, or custom solutions using RDF frameworks. | |
| Data & Libraries | Curated Natural Product Databases | Provides ground-truth data for training AI models and for dereplication [84] [87]. | COCONUT, NP Atlas, LOTUS, in-house spectral libraries. |
| Ultra-Large Virtual Compound Libraries | Provides billions of synthesizable structures for virtual screening alongside CASE candidates [88]. | Enamine REAL Space, ZINC, SAVI [88]. | |
| Pre-trained AI Models | Off-the-shelf models for property prediction (ADMET, pKa, logP) and spectral simulation [91] [89]. | Attentive FP models (e.g., AttenhERG for toxicity) [89], QM/ML models for property prediction [91]. | |
| Instrumentation & Analysis | High-Field NMR with Cryoprobes | Generates high-resolution, sensitive 1D and 2D NMR data, the primary input for structure-focused AI models. | 600 MHz+ spectrometers; essential for complex NPs [92]. |
| High-Resolution LC-MS/MS Systems | Provides exact mass and fragmentation data for molecular formula determination and AI-based spectral matching. | Q-TOF or Orbitrap systems coupled with UHPLC. | |
| Automated Fractionation & Microtiter Platforms | Generates the purified samples and bioactivity data that feed into the CASE and KG workflows. | Enables high-throughput generation of training and validation data. |
The integration of AI into CASE is not merely theoretical but is delivering measurable improvements in key performance metrics. These advancements directly address the core challenges of time, cost, and success rates in natural product-based drug discovery.
Speed Enhancements: AI dramatically accelerates the most time-consuming steps. For instance, retrosynthesis planning using neural-symbolic frameworks and Monte Carlo Tree Search can generate expert-quality synthetic routes in minutes, a task that previously took human experts days [91]. In virtual screening, GPU-accelerated docking and ML-based scoring functions enable the screening of ultra-large libraries (billions of compounds) in practical timeframes, a process that was computationally prohibitive a few years ago [88] [86]. Spectral analysis is also expedited; ML models can predict NMR chemical shifts or assign spectra in seconds, compared to hours of manual analysis.
Accuracy Improvements: The predictive accuracy of AI models directly translates to more reliable structure elucidation. Hybrid QM/ML models achieve near-quantum mechanical accuracy for predicting properties like free energy of binding or pKa while being several orders of magnitude faster [91]. For binding affinity prediction, modern GNN and transformer-based models consistently outperform classical scoring functions, reducing false positives in virtual screening [89]. In generative design, models like NPDL-GEN produce molecules with high validity (>95%), uniqueness, and improved drug-likeness profiles, ensuring that proposed structures are both chemically realistic and therapeutically relevant [90].
Table 3: Quantitative Impact of AI/ML on Key Drug Discovery Parameters
| Performance Metric | Traditional / Baseline Approach | AI-Enhanced Approach | Documented Improvement / Impact | Source |
|---|---|---|---|---|
| Virtual Screening Hit Rate | Typically 1-10% from HTS or standard VS. | Structure-based VS with ML scoring on ultra-large libraries. | Hit rates of 10-40% reported, with identification of nM-potency leads [88]. | [88] |
| Retrosynthesis Route Planning Speed | Human expert requires hours to days per molecule. | Neural-symbolic AI with MCTS. | Generates expert-quality routes in minutes to seconds [91]. | [91] |
| Free Energy Calculation Speed | Ab initio QM methods: high accuracy but extremely slow. | Hybrid QM/ML models. | Achieves high accuracy at computational cost reduced by several orders of magnitude [91]. | [91] |
| Property Prediction (ADMET) Accuracy | Traditional QSAR models with limited descriptors. | Deep learning models (e.g., Graph Neural Networks). | Consistently achieve state-of-the-art accuracy in benchmarks (e.g., Attentive FP for hERG) [89]. | [89] |
| Generative Model Output Quality | Early generators produced many invalid/unnatural structures. | Advanced architectures (GPT + AHC optimization). | Generates molecules with >95% validity, high novelty, and optimized drug-likeness [90]. | [90] |
| Overall R&D Cost & Timeline | Average cost ~$2.6B and 10-15 years per drug. | CADD/AI integration across pipeline. | Estimated to reduce discovery costs by up to 50% and significantly shorten timelines [88] [86]. | [88] [86] |
The integration of AI and ML into Computer-Assisted Structure Elucidation marks a paradigm shift for natural products research. As detailed in these application notes and protocols, AI is not a standalone tool but a synergistic force that enhances every stage of the workflow—from rapid, accurate interpretation of complex spectroscopic data to the generative design of novel analogs and the integrative reasoning provided by knowledge graphs. This directly contributes to the core thesis that modern CASE must evolve into an intelligent, predictive, and context-aware framework to fully unlock the potential of natural products.
Future advancements within this field will likely focus on several key areas. First, the development of foundational models for chemistry, pre-trained on massive, multimodal datasets, which can be fine-tuned for specific CASE tasks with limited data, addressing the challenge of small, imbalanced NP datasets [85]. Second, the tighter integration of robotic and automated laboratory systems with AI platforms will close the loop between in silico prediction and in vitro validation, creating self-driving "laboratories" for NP discovery [85] [86]. Finally, as AI models become more central, ensuring their interpretability and reliability through uncertainty quantification and applicability domain estimation will be critical for gaining the trust of researchers and meeting regulatory standards [85]. By embracing these directions, the next generation of CASE systems will not only elucidate structures faster but will also intelligently predict their function, synthesis, and therapeutic value, radically accelerating the translation of natural product complexity into clinical opportunity.
Determining the correct three-dimensional structure of a natural product is a foundational step in drug discovery, as biological activity is intimately governed by molecular architecture [93]. An erroneous structural assignment can derail a research program, wasting years of effort and resources. High-profile cases, such as the anticancer candidate TIC10, underscore the severe consequences—including legal disputes over intellectual property—when a published structure is later revised [93]. While techniques like NMR spectroscopy and X-ray crystallography are indispensable, the interpretation of complex spectroscopic data for novel, intricate natural products remains a significant inverse problem, inherently susceptible to investigator bias [93] [4]. Computer-Assisted Structure Elucidation (CASE) systems have emerged as a transformative preventive tool. By applying logical-combinatorial algorithms and leveraging comprehensive databases, CASE provides an objective, systematic framework for structure generation and ranking. This methodology minimizes human error at the outset, thereby preventing the costly and reputation-damaging revisions that occur when misassignments are discovered years later through total synthesis or computational re-analysis [93] [4].
The following protocols outline a standardized, preventive workflow for de novo structure elucidation of natural products using a modern CASE system, such as the ACD/Structure Elucidator Suite [34].
The reliability of a CASE solution is directly contingent on the quality and completeness of the input spectroscopic data.
The MCD is a 2D map of atom connectivity inferred from the spectral data and is the cornerstone of the CASE process [34].
This protocol transforms the MCD into a ranked list of candidate structures.
Table 1: Key Features of a Modern CASE Software Platform (e.g., ACD/Structure Elucidator Suite) [34]
| Feature Category | Specific Function | Role in Error Prevention |
|---|---|---|
| Data Integration | Vendor-neutral import of NMR, MS, IR data | Prevents manual transcription errors, ensures data consistency |
| Connectivity Mapping | Automated Molecular Connectivity Diagram (MCD) generation | Provides an objective, visual map of data constraints before interpretation bias occurs |
| Knowledge Integration | Editable MCD with user-defined fragment libraries (e.g., 2.2+ million fragments) | Allows incorporation of prior chemical knowledge (e.g., biosynthetic precursors) to guide the solver |
| Structure Generation | Deterministic structure generator creating all isomers fitting constraints | Ensures the correct structure is within the evaluated set, preventing oversight |
| Prediction & Ranking | Neural network/HOSE-based chemical shift prediction; ranking by average deviation (dₙ) | Provides an unbiased, quantitative comparison of candidate fits to experimental data |
| Statistical Validation | DP4 probability analysis | Offers a robust statistical measure to confirm the top candidate, reducing reliance on intuition |
| Dereplication | Search against internal & external databases (e.g., PubChem) | Immediately identifies known compounds, preventing redundant "rediscovery" and misassignment |
CASE is not only a tool for solving unknown structures but also a powerful independent auditor for validating published assignments and diagnosing errors in proposed structures.
Scenario: A newly isolated compound or a literature structure exhibits biological activity, but the proposed structure feels anomalous or synthetic efforts fail.
Validation Protocol:
Case Study – Aldingenin C [93]:
Table 2: Documented Structural Revisions Resolved via Computational and CASE Methods [93]
| Natural Product | Original Structure Issue | Method Used for Revision | Key to Correction |
|---|---|---|---|
| Aldingenins A-D | Incorrect carbon skeleton & halogen placement | CASE analysis & synthesis | CASE identified structures as known caespitols; rFF computational NMR confirmed. |
| Decurrensides A-E | Incorrect hemiacetal/anhydro core configuration | DFT-GIAO δc & rFF J-coupling calculations | Computed ¹³C shifts and coupling constants of proposed structure deviated severely from experiment. |
| Tristichone C | Misassigned positions of Br and Cl atoms | rFF with quadratic scaling for halogen shifts | Predicted δC for Cl-bearing carbon in original structure deviated by 6.6 ppm; isomer fit perfectly. |
| Glabramycins B & C | Likely incorrect stereochemistry or substitution | Not specified in excerpt; commonly DP4 analysis | CASE and DP4 analysis of stereoisomers can identify the best-fit configuration. |
Table 3: Key Research Reagent Solutions and Materials for CASE Experiments
| Item | Function in CASE Workflow | Critical Specifications & Notes |
|---|---|---|
| High-Field NMR Spectrometer | Acquires the essential 2D NMR data (HSQC, HMBC, COSY). | Field Strength: ≥ 500 MHz for ¹H frequency. Probe: Cryogenically cooled inverse detection probe for sensitivity; preferably equipped for ¹H-¹³C and ¹H-¹⁵N. |
| High-Resolution Mass Spectrometer | Determines the exact molecular formula, a primary constraint for structure generation. | Resolution: > 30,000 (FWHM). Accuracy: < 3 ppm mass error. Modes: ESI⁺/⁻, APCI, etc., as suitable for the analyte. |
| CASE Software Suite | The core platform for data integration, MCD generation, structure generation, and prediction. | Essential Features: Vendor-neutral data import, editable MCD, deterministic structure generator, high-accuracy NMR predictor (neural net/HOSE), statistical validation tools (DP4), and dereplication links [34]. |
| Fragment & Chemical Databases | Enables dereplication and provides prior knowledge for MCD editing. | Examples: Internal CASE fragment library (2M+ fragments), PubChem, CAS SciFinderⁿ, Dictionary of Natural Products. Integrated searching is key [34]. |
| Deuterated NMR Solvents | Provides the lock signal and solvent environment for NMR experiments. | Grade: 99.8+% D. Common solvents: CDCl₃, DMSO-d₆, CD₃OD, D₂O. Must be dry and appropriate for the sample. |
| Reference Compounds | Used for spectral calibration and as internal standards for chemical shift referencing. | Example: Tetramethylsilane (TMS) at 0.0 ppm. Alternatively, residual solvent peaks can be used (e.g., CHCl₃ in CDCl₃ at 7.26 ppm for ¹H). |
Within the broader thesis on Computer-Assisted Structure Elucidation (CASE) for natural products research, the imperative to objectively evaluate the performance of these expert systems is paramount [22] [1]. The structure elucidation of complex natural products remains a significant intellectual challenge, with a persistent risk of incorrect assignments appearing in the literature [1] [11]. CASE systems, which synergistically combine spectroscopic data (primarily NMR and MS) with computational chemistry and algorithmic structure generation, promise to mitigate this risk by ensuring all plausible structural candidates consistent with the data are considered [22] [53]. This document provides detailed application notes and protocols for benchmarking the performance of CASE platforms. It focuses on assessing their efficacy in solving structures of known compounds (thereby validating the method) and explicitly underscores the inherent limitations encountered with specific structural classes or data quality issues [94] [53]. The goal is to furnish researchers and drug development professionals with a standardized framework for evaluating and implementing CASE in their natural product discovery workflows [11].
The most rigorous assessment of CASE software comes from blind trials, where the solution is unknown to the analyst. A long-term, global study involving 112 challenges provides key quantitative metrics for benchmarking [53].
Table 1: Summary of Blind Trial Performance for a CASE System (ACD/Structure Elucidator)
| Performance Metric | Result | Details & Context |
|---|---|---|
| Total Challenges Analyzed | 112 | Collected over ~9 years from academic (50%), pharmaceutical (42%), industrial (5%), and government (3%) sectors [53]. |
| Double-Blind Trials | 10 (9%) | Structure unknown to both submitter and analyst; high scientific value [53]. |
| Success Rate (Agreement) | 100 challenges (89.3%) | "Double Agreement" (structure validated) and "Single Agreement" (top candidate not formally confirmed) [53]. |
| Failure Rate (Incorrect/Rejected) | 12 challenges (10.7%) | Incorrect solutions or data rejected due to poor quality or insufficiency [53]. |
| Average Total Processing Time | ~84 minutes (~1.4 hours) | Includes spectral data processing, dereplication, and structure generation [53]. |
| Average Structure Generation Time | >25 minutes | Generates an average of ~2,639 candidate structures per challenge [53]. |
| Dereplication Library Search Time | ~3 minutes | Searched against a library of >19 million records with 13C chemical shift data [53]. |
Performance is heavily influenced by the nature of the molecular problem. The table below categorizes challenges that increase complexity and risk of failure.
Table 2: Problem Complexity and Associated CASE Limitations
| Challenge Category | Impact on CASE Performance | Potential Outcome |
|---|---|---|
| Deficiency in Protons | Limits available 1H-13C correlation data (HSQC), reducing constraints. | Increased number of candidate structures; possible failure [1] [53]. |
| High Molecular Symmetry | Reduces the number of independent structural constraints from NMR data. | Ambiguity in structure generation; can produce incorrect, overly symmetric solutions [53]. |
| Large Number of Heteroatoms (N, O, S, P) | Expands the combinatorial possibilities for atom connectivity. | Explosive growth in candidate structures; requires very high-quality HMBC data [53]. |
| Poor Quality Spectral Data | Low S/N, incorrect peak picking, impurities lead to false or missing constraints. | Generation of incorrect structures or failure to generate any valid structure [53]. |
| Very Large Molecules (>1000 Da) | Surpassed software algorithm limits in earlier versions. | Software failure; limitations typically addressed in subsequent updates [53]. |
| Non-Standard Correlations (>3 bonds) | Violates the standard HMBC assumption, creating "contradictory" constraints. | May be flagged as "problematic" peaks; requires expert intervention to manage [1]. |
Objective: To generate comprehensive, high-quality spectroscopic data for an unknown natural product suitable for CASE analysis.
Objective: To input spectroscopic data into a CASE system and generate all plausible structural candidates.
Objective: To conclusively verify the top-ranked CASE candidate as the correct structure.
Diagram 1: CASE Workflow and Validation Protocol [1] [53] [11]
Diagram 2: Diagnostic Logic for Common CASE Limitations [1] [53]
Table 3: Key Reagents, Software, and Databases for CASE
| Item / Resource | Function / Purpose | Notes & Examples |
|---|---|---|
| Deuterated NMR Solvents | Provide a signal-free lock and field-frequency stabilization for NMR experiments. Essential for 2D NMR. | DMSO-d6, CDCl3, CD3OD, D2O. Purity should be >99.9% D. |
| NMR Reference Standards | Provide internal chemical shift calibration for 1H and 13C spectra. | Tetramethylsilane (TMS, δ = 0 ppm) or residual solvent peaks. |
| CASE Expert Software | Core platform for algorithmic structure generation from spectroscopic constraints. | ACD/Structure Elucidator, SpecInfo, CMC-se [1] [53]. |
| Quantum Chemistry Software | Perform DFT calculations to optimize geometry and predict NMR shifts for validation. | Gaussian, GAMESS, ORCA. Used for DP4 analysis [11]. |
| Natural Product Databases | For dereplication: comparing data of unknown compounds against known compounds. | COCONUT (~400k NPs) [95], AntiBase, MarinLit, GNPS [11]. |
| Spectral Libraries | For dereplication via spectral matching, especially MS and 13C NMR. | Integrated in CASE software (e.g., >19M 13C records) [53] or public (NIST MS, MassBank). |
| Cheminformatics Toolkits | For handling, standardizing, and analyzing chemical structures in silico. | RDKit, Chemistry Development Kit (CDK) [94] [95]. |
While CASE systems have matured into indispensable tools, critical limitations persist. Their primary output is the planar (2D) molecular structure [1]. Determining relative and absolute configuration (stereochemistry) often requires additional, specialized NMR experiments (e.g., NOESY, ROESY, J-based configurational analysis) or computational methods like DFT-based optical rotation calculation [22] [11]. Furthermore, CASE algorithms operate on defined assumptions, most notably that HMBC correlations represent 2- or 3-bond couplings. "Non-standard" correlations (e.g., over 4 bonds or through heteroatoms) can cause contradictions that require expert intervention to resolve [1].
The future "golden age" of CASE lies in deeper integration [22]. This includes synergy with:
For the natural products researcher, the pragmatic approach is to view the CASE system not as an autonomous oracle, but as a powerful co-pilot. The synergistic interaction between the chemist's chemical intuition and the computer's exhaustive, unbiased search capability dramatically improves the speed, throughput, and reliability of structure elucidation [53] [11]. Benchmarking, as outlined in these protocols, is the essential first step to adopting this partnership effectively.
Computer-Assisted Structure Elucidation (CASE) has matured into an indispensable, high-throughput tool that fundamentally accelerates and secures the discovery pipeline for natural products and drug candidates. By synthesizing the foundational principles, robust methodologies, targeted troubleshooting, and rigorous validation protocols explored in this article, researchers can confidently apply CASE to solve increasingly complex structural challenges. Future directions point toward deeper integration of artificial intelligence and machine learning for predictive accuracy, greater automation bridging data acquisition and interpretation, and expanded use in stereochemical determination and metabolomics. These advancements promise to further streamline biomedical research, reduce costly errors in structural assignments, and accelerate the translation of novel natural products into clinical therapies.